Publications

Publications published since 2008 from OUS - Center for Clinical Heart Research

278 publications found

Publications 2019

  1. Abdelnoor M, Sandven I, Vengen Ø, Risnes I (2019)
    Mediastinitis in open heart surgery: a systematic review and meta-analysis of risk factors
    Scand Cardiovasc J
    DOI 10.1080/14017431.2019.1642508, PubMed 31290699
  2. Atar D, Grundvold I (2019)
    On-label reduced doses of non-vitamin K anticoagulants prove safe and efficient; yet how to ensure the correct dose for the right patient?
    Eur Heart J, 40 (19), 1501-1503
    DOI 10.1093/eurheartj/ehz014, PubMed 30753396
  3. Awoyemi A, Trøseid M, Arnesen H, Solheim S, Seljeflot I (2019)
    Effects of dietary intervention and n-3 PUFA supplementation on markers of gut-related inflammation and their association with cardiovascular events in a high-risk population
    Atherosclerosis, 286, 53-59
    DOI 10.1016/j.atherosclerosis.2019.05.004, PubMed 31100620
  4. Bratseth V, Chiva-Blanch G, Byrkjeland R, Solheim S, Arnesen H, Seljeflot I (2019)
    Elevated levels of circulating microvesicles in coronary artery disease patients with type 2 diabetes and albuminuria: Effects of exercise training
    Diab Vasc Dis Res, 16 (5), 431-439
    DOI 10.1177/1479164119843094, PubMed 31023084
  5. Chiva-Blanch G, Laake K, Myhre P, Bratseth V, Arnesen H, Solheim S, Badimon L, Seljeflot I (2019)
    High Adherence to the Nordic Diet Is Associated with Lower Levels of Total and Platelet-Derived Circulating Microvesicles in a Norwegian Population
    Nutrients, 11 (5)
    DOI 10.3390/nu11051114, PubMed 31109111
  6. Cwikiel J, Seljeflot I, Fagerland MW, Wachtell K, Arnesen H, Berge E, Flaa A (2019)
    High-sensitive cardiac Troponin T and exercise stress test for evaluation of angiographically significant coronary disease
    Int J Cardiol, 287, 1-6
    DOI 10.1016/j.ijcard.2019.04.019, PubMed 31006595
  7. Danielsen SO, Moons P, Sandvik L, Leegaard M, Solheim S, Tønnessen T, Lie I (2019)
    Impact of telephone follow-up and 24/7 hotline on 30-day readmission rates following aortic valve replacement -A randomized controlled trial
    Int J Cardiol (in press)
    DOI 10.1016/j.ijcard.2019.07.087, PubMed 31387822
  8. Ellingsen DG, Chashchin M, Seljeflot I, Berlinger B, Chashchin V, Stockfelt L, Thomassen Y (2019)
    A study of atherothrombotic biomarkers in welders
    Int Arch Occup Environ Health (in press)
    DOI 10.1007/s00420-019-01441-4, PubMed 31114965
  9. Eritsland J, Andersen GO (2019)
    MR findings of microvascular perfusion in infarcted and remote myocardium early after successful primary PCI (vol 13, e0206723, 2018)
    PLoS One, 14 (3), e0213636
  10. Holte KB, Svanteson M, Hanssen KF, Haig Y, Solheim S, Berg TJ (2019)
    Undiagnosed coronary artery disease in long-term type 1 diabetes. The Dialong study
    J Diabetes Complications, 33 (5), 383-389
    DOI 10.1016/j.jdiacomp.2019.01.006, PubMed 30846232
  11. Knudsen EC, Seljeflot I, Aksnes TA, Eritsland J, Arnesen H, Andersen GØ (2019)
    IgM antibodies against phosphorylcholine measured early after acute ST-elevation myocardial infarction in relation to atherosclerotic disease burden and long-term clinical outcome
    PLoS One, 14 (4), e0215640
    DOI 10.1371/journal.pone.0215640, PubMed 31002684
  12. Mariampillai JE, Prestgaard EE, Kjeldsen SE, Liestøl K, Engeseth K, Erikssen J, Bodegard J, Berge E, Grundvold I, Skretteberg PT (2019)
    SBP above 180 mmHg at moderate exercise workload increases coronary heart disease risk in healthy men during 28-year follow-up
    J Hypertens, 37 (5), 949-955
    DOI 10.1097/HJH.0000000000001959, PubMed 30325341
  13. Mayerhofer CCK, Awoyemi A, Hov JR, Trøseid M, Broch K (2019)
    Reply: Potential risk associated with direct modulation of the gut flora in patients with heart failure
    ESC Heart Fail, 6 (3), 557-558
    DOI 10.1002/ehf2.12437, PubMed 31034162
  14. Opstad TB, Kalstad AA, Pettersen AÅ, Arnesen H, Seljeflot I (2019)
    Novel biomolecules of ageing, sex differences and potential underlying mechanisms of telomere shortening in coronary artery disease
    Exp Gerontol, 119, 53-60
    DOI 10.1016/j.exger.2019.01.020, PubMed 30684534
  15. Røe ÅT, Ruud M, Espe EK, Manfra O, Longobardi S, Aronsen JM, Nordén ES, Husebye T, Kolstad TRS, Cataliotti A, Christensen G, Sejersted OM, Niederer SA, Andersen GØ, Sjaastad I, Louch WE (2019)
    Regional diastolic dysfunction in post-infarction heart failure: role of local mechanical load and SERCA expression
    Cardiovasc Res, 115 (4), 752-764
    DOI 10.1093/cvr/cvy257, PubMed 30351410
  16. Schultz NH, Holme PA, Henriksson CE, Mowinckel MC, Sandset PM, Bratseth V, Jacobsen EM (2019)
    The influence of rivaroxaban on markers of fibrinolysis and endothelial cell activation/injury in patients with venous thrombosis
    Thromb Res, 177, 154-156
    DOI 10.1016/j.thromres.2019.03.010, PubMed 30903875
  17. Solberg OG, Stavem K, Ragnarsson A, Beitnes JO, Skårdal R, Seljeflot I, Ueland T, Aukrust P, Gullestad L, Aaberge L (2019)
    Index of microvascular resistance to assess the effect of rosuvastatin on microvascular function in women with chest pain and no obstructive coronary artery disease: A double-blind randomized study
    Catheter Cardiovasc Interv (in press)
    DOI 10.1002/ccd.28157, PubMed 30790446
  18. Warlo EMK, Arnesen H, Seljeflot I (2019)
    A brief review on resistance to P2Y12 receptor antagonism in coronary artery disease
    Thromb J, 17, 11
    DOI 10.1186/s12959-019-0197-5, PubMed 31198410
  19. Zaidi H, Byrkjeland R, Njerve IU, Åkra S, Solheim S, Arnesen H, Seljeflot I, Opstad TB (2019)
    Effects of exercise training on inflammasome-related mediators and their associations to glucometabolic variables in patients with combined coronary artery disease and type 2 diabetes mellitus: Sub-study of a randomized control trial
    Diab Vasc Dis Res, 16 (4), 360-368
    DOI 10.1177/1479164119836922, PubMed 30939905

Publications 2018

  1. Awoyemi A, Trøseid M, Arnesen H, Solheim S, Seljeflot I (2018)
    Markers of metabolic endotoxemia as related to metabolic syndrome in an elderly male population at high cardiovascular risk: a cross-sectional study
    Diabetol Metab Syndr, 10, 59
    DOI 10.1186/s13098-018-0360-3, PubMed 30038669
  2. Bethke A, Shanmuganathan L, Andersen GØ, Eritsland J, Swanson D, Kløw NE, Hoffmann P (2018)
    Microvascular perfusion in infarcted and remote myocardium after successful primary PCI: angiographic and CMR findings
    Eur Radiol, 29 (2), 941-950
    DOI 10.1007/s00330-018-5588-7, PubMed 29980929
  3. Bethke A, Shanmuganathan L, Shetelig C, Swanson D, Andersen GØ, Eritsland J, Kløw NE, Hoffmann P (2018)
    MR findings of microvascular perfusion in infarcted and remote myocardium early after successful primary PCI
    PLoS One, 13 (11), e0206723
    DOI 10.1371/journal.pone.0206723, PubMed 30412607
  4. Cwikiel J, Seljeflot I, Berge E, Njerve IU, Ulsaker H, Arnesen H, Flaa A (2018)
    Effect of strenuous exercise on mediators of inflammation in patients with coronary artery disease
    Cytokine, 105, 17-22
    DOI 10.1016/j.cyto.2018.02.006, PubMed 29433015
  5. Danielsen SO, Moons P, Sandven I, Leegaard M, Solheim S, Tønnessen T, Lie I (2018)
    Thirty-day readmissions in surgical and transcatheter aortic valve replacement: A systematic review and meta-analysis
    Int J Cardiol, 268, 85-91
    DOI 10.1016/j.ijcard.2018.05.026, PubMed 29779575
  6. Dhillon AK, Kummen M, Trøseid M, Åkra S, Liaskou E, Moum B, Vesterhus M, Karlsen TH, Seljeflot I, Hov JR (2018)
    Circulating markers of gut barrier function associated with disease severity in primary sclerosing cholangitis
    Liver Int, 39 (2), 371-381
    DOI 10.1111/liv.13979, PubMed 30269440
  7. Engeseth K, Prestgaard EE, Mariampillai JE, Grundvold I, Liestol K, Kjeldsen SE, Bodegard J, Erikssen JE, Gjesdal K, Skretteberg PT (2018)
    Physical fitness is a modifiable predictor of early cardiovascular death: A 35-year follow-up study of 2014 healthy middle-aged men
    Eur J Prev Cardiol, 25 (15), 1655-1663
    DOI 10.1177/2047487318793459, PubMed 30103630
  8. Hansen CH, Ritschel V, Andersen GØ, Halvorsen S, Eritsland J, Arnesen H, Seljeflot I (2018)
    Markers of Thrombin Generation Are Associated With Long-Term Clinical Outcome in Patients With ST-Segment Elevation Myocardial Infarction
    Clin Appl Thromb Hemost, 24 (7), 1088-1094
    DOI 10.1177/1076029618764847, PubMed 29695176
  9. Heier M, Espeland CN, Brunborg C, Seljeflot I, Margeirsdottir HD, Hanssen KF, Fugelseth D, Dahl-Jørgensen K (2018)
    Preserved endothelial function in young adults with type 1 diabetes
    PLoS One, 13 (10), e0206523
    DOI 10.1371/journal.pone.0206523, PubMed 30359432
  10. Heier M, Stensæth KH, Brunborg C, Seljeflot I, Margeirsdottir HD, Hanssen KF, Dahl-Jørgensen K (2018)
    Increased arterial stiffness in childhood onset diabetes: a cardiovascular magnetic resonance study
    Eur Heart J Cardiovasc Imaging, 19 (6), 694-700
    DOI 10.1093/ehjci/jex178, PubMed 28950341
  11. Hiis HG, Cosson MV, Dahl CP, Fiane AE, Levy FO, Andersen GØ, Krobert KA (2018)
    Hypothermia elongates the contraction-relaxation cycle in explanted human failing heart decreasing the time for ventricular filling during diastole
    Am J Physiol Heart Circ Physiol, 315 (5), H1137-H1147
    DOI 10.1152/ajpheart.00208.2018, PubMed 30004809
  12. Hoel H, Hove-Skovsgaard M, Hov JR, Gaardbo JC, Holm K, Kummen M, Rudi K, Nwosu F, Valeur J, Gelpi M, Seljeflot I, Ueland PM, Gerstoft J, Ullum H, Aukrust P, Nielsen SD, Trøseid M (2018)
    Impact of HIV and Type 2 diabetes on Gut Microbiota Diversity, Tryptophan Catabolism and Endothelial Dysfunction
    Sci Rep, 8 (1), 6725
    DOI 10.1038/s41598-018-25168-3, PubMed 29712976
  13. Horjen AW, Ulimoen SR, Norseth J, Svendsen JH, Smith P, Arnesen H, Seljeflot I, Tveit A (2018)
    High-sensitivity troponin I in persistent atrial fibrillation - relation to NT-proBNP and markers of inflammation and haemostasis
    Scand J Clin Lab Invest, 78 (5), 386-392
    DOI 10.1080/00365513.2018.1481224, PubMed 29933716
  14. Langseth MS, Opstad TB, Bratseth V, Solheim S, Arnesen H, Pettersen AÅ, Seljeflot I, Helseth R (2018)
    Markers of neutrophil extracellular traps are associated with adverse clinical outcome in stable coronary artery disease
    Eur J Prev Cardiol, 25 (7), 762-769
    DOI 10.1177/2047487318760618, PubMed 29473463
  15. Mayerhofer CCK, Awoyemi AO, Moscavitch SD, Lappegård KT, Hov JR, Aukrust P, Hovland A, Lorenzo A, Halvorsen S, Seljeflot I, Gullestad L, Trøseid M, Broch K (2018)
    Design of the GutHeart-targeting gut microbiota to treat heart failure-trial: a Phase II, randomized clinical trial
    ESC Heart Fail, 5 (5), 977-984
    DOI 10.1002/ehf2.12332, PubMed 30088346
  16. Munkhaugen J, Hjelmesæth J, Otterstad JE, Helseth R, Sollid ST, Gjertsen E, Gullestad L, Perk J, Moum T, Husebye E, Dammen T (2018)
    Managing patients with prediabetes and type 2 diabetes after coronary events: individual tailoring needed - a cross-sectional study
    BMC Cardiovasc Disord, 18 (1), 160
    DOI 10.1186/s12872-018-0896-z, PubMed 30075751
  17. Orrem HL, Nilsson PH, Pischke SE, Grindheim G, Garred P, Seljeflot I, Husebye T, Aukrust P, Yndestad A, Andersen GØ, Barratt-Due A, Mollnes TE (2018)
    Acute heart failure following myocardial infarction: complement activation correlates with the severity of heart failure in patients developing cardiogenic shock
    ESC Heart Fail, 5 (3), 292-301
    DOI 10.1002/ehf2.12266, PubMed 29424484
  18. Orrem HL, Nilsson PH, Pischke SE, Kleveland O, Yndestad A, Ekholt K, Damås JK, Espevik T, Bendz B, Halvorsen B, Gregersen I, Wiseth R, Andersen GØ, Ueland T, Gullestad L, Aukrust P, Barratt-Due A, Mollnes TE (2018)
    IL-6 Receptor Inhibition by Tocilizumab Attenuated Expression of C5a Receptor 1 and 2 in Non-ST-Elevation Myocardial Infarction
    Front Immunol, 9, 2035
    DOI 10.3389/fimmu.2018.02035, PubMed 30258440
  19. Orrem HL, Shetelig C, Ueland T, Limalanathan S, Nilsson PH, Husebye T, Aukrust P, Seljeflot I, Hoffmann P, Eritsland J, Mollnes TE, Andersen GØ, Yndestad A (2018)
    Soluble IL-1 receptor 2 is associated with left ventricular remodelling in patients with ST-elevation myocardial infarction
    Int J Cardiol, 268, 187-192
    DOI 10.1016/j.ijcard.2018.05.032, PubMed 29853279
  20. Prestgaard E, Mariampillai J, Engeseth K, Erikssen J, Bodegård J, Liestøl K, Gjesdal K, Kjeldsen S, Grundvold I, Berge E (2018)
    Change in Cardiorespiratory Fitness and Risk of Stroke and Death
    Stroke, 50 (1), 155-161
    DOI 10.1161/STROKEAHA.118.021798, PubMed 30580727
  21. Rocca B, Fox KAA, Ajjan RA, Andreotti F, Baigent C, Collet JP, Grove EL, Halvorsen S, Huber K, Morais J, Patrono C, Rubboli A, Seljeflot I, Sibbing D, Siegbahn A, Ten Berg J, Vilahur G, Verheugt FWA, Wallentin L, Weiss TW, Wojta J, Storey RF (2018)
    Antithrombotic therapy and body mass: an expert position paper of the ESC Working Group on Thrombosis
    Eur Heart J, 39 (19), 1672-1686f
    DOI 10.1093/eurheartj/ehy066, PubMed 29509886
  22. Saetre E, Abdelnoor M (2018)
    Incidence rate of sudden death in epilepsy: A systematic review and meta-analysis
    Epilepsy Behav, 86, 193-199
    DOI 10.1016/j.yebeh.2018.06.037, PubMed 30017838
  23. Shetelig C, Limalanathan S, Hoffmann P, Seljeflot I, Gran JM, Eritsland J, Andersen GØ (2018)
    Association of IL-8 With Infarct Size and Clinical Outcomes in Patients With STEMI
    J Am Coll Cardiol, 72 (2), 187-198
    DOI 10.1016/j.jacc.2018.04.053, PubMed 29976293
  24. Staer-Jensen H, Sunde K, Nakstad ER, Eritsland J, Andersen GØ (2018)
    Comparison of three haemodynamic monitoring methods in comatose post cardiac arrest patients
    Scand Cardiovasc J, 52 (3), 141-148
    DOI 10.1080/14017431.2018.1450992, PubMed 29544369
  25. Åkra S, Aksnes TA, Flaa A, Eggesbø HB, Opstad TB, Njerve IU, Seljeflot I (2018)
    Interleukin-18 and the NLR family pyrin domain containing-3 inflammasome in adipose tissue are strongly associated with glucometabolic variables in a cohort of middle-aged men
    Diab Vasc Dis Res, 15 (5), 458-464
    DOI 10.1177/1479164118785307, PubMed 29972041

Publications 2017

  1. Abdelnoor M, Andersen JG, Arnesen H, Johansen O (2017)
    Early discharge compared with ordinary discharge after percutaneous coronary intervention - a systematic review and meta-analysis of safety and cost
    Vasc Health Risk Manag, 13, 101-109
    DOI 10.2147/VHRM.S122951, PubMed 28356750
  2. Bratseth V, Byrkjeland R, Njerve IU, Solheim S, Arnesen H, Seljeflot I (2017)
    Procoagulant activity in patients with combined type 2 diabetes and coronary artery disease: No effects of long-term exercise training
    Diab Vasc Dis Res, 14 (2), 144-151
    DOI 10.1177/1479164116679080, PubMed 28111966
  3. Byrkjeland R, Njerve IU, Arnesen H, Seljeflot I, Solheim S (2017)
    Reduced endothelial activation after exercise is associated with improved HbA1c in patients with type 2 diabetes and coronary artery disease
    Diab Vasc Dis Res, 14 (2), 94-103
    DOI 10.1177/1479164116679077, PubMed 28111980
  4. Chiva-Blanch G, Laake K, Myhre P, Bratseth V, Arnesen H, Solheim S, Badimon L, Seljeflot I (2017)
    Platelet-, monocyte-derived and tissue factor-carrying circulating microparticles are related to acute myocardial infarction severity
    PLoS One, 12 (2), e0172558
    DOI 10.1371/journal.pone.0172558, PubMed 28207887
  5. Cwikiel J, Seljeflot I, Berge E, Arnesen H, Wachtell K, Ulsaker H, Flaa A (2017)
    Pro-coagulant activity during exercise testing in patients with coronary artery disease
    Thromb J, 15, 3
    DOI 10.1186/s12959-016-0127-8, PubMed 28115916
  6. Ellingsen DG, Seljeflot I, Thomassen Y, Thomassen M, Bakke B, Ulvestad B (2017)
    Biomarkers of endothelial activation and thrombosis in tunnel construction workers exposed to airborne contaminants
    Int Arch Occup Environ Health, 90 (4), 309-317
    DOI 10.1007/s00420-017-1199-x, PubMed 28124139
  7. Gharagozlian S, Hansen R, Haugen M, Johansen O, Seierstad SL, Seljeflot I, Arnesen H (2017)
    Changes in dietary pattern when including 700 g of salmon per week to patients with atherosclerotic heart disease
    Clin. Nutr. ESPEN, 19, 38-44
  8. Heier M, Borja MS, Brunborg C, Seljeflot I, Margeirsdottir HD, Hanssen KF, Dahl-Jørgensen K, Oda MN (2017)
    Reduced HDL function in children and young adults with type 1 diabetes
    Cardiovasc Diabetol, 16 (1), 85
    DOI 10.1186/s12933-017-0570-2, PubMed 28683835
  9. Horjen AW, Seljeflot I, Berge T, Smith P, Arnesen H, Tveit A (2017)
    Effect of sinus rhythm restoration on markers of thrombin generation in atrial fibrillation
    Thromb J, 15, 30
    DOI 10.1186/s12959-017-0153-1, PubMed 29299030
  10. Hove-Skovsgaard M, Gaardbo JC, Kolte L, Winding K, Seljeflot I, Svardal A, Berge RK, Gerstoft J, Ullum H, Trøseid M, Nielsen SD (2017)
    HIV-infected persons with type 2 diabetes show evidence of endothelial dysfunction and increased inflammation
    BMC Infect Dis, 17 (1), 234
    DOI 10.1186/s12879-017-2334-8, PubMed 28356058
  11. Husebye T, Eritsland J, Bjørnerheim R, Andersen GØ (2017)
    Systolic mitral annulus velocity is a sensitive index for changes in left ventricular systolic function during inotropic therapy in patients with acute heart failure
    Eur Heart J Acute Cardiovasc Care, 7 (4), 321-329
    DOI 10.1177/2048872616687114, PubMed 28045338
  12. Kvakkestad KM, Sandvik L, Andersen GØ, Sunde K, Halvorsen S (2017)
    Long-term survival in patients with acute myocardial infarction and out-of-hospital cardiac arrest: A prospective cohort study
    Resuscitation, 122, 41-47
    DOI 10.1016/j.resuscitation.2017.11.047, PubMed 29155294
  13. Lie I, Danielsen SO, Tønnessen T, Solheim S, Leegaard M, Sandvik L, Wisløff T, Vangen J, Røsstad TH, Moons P (2017)
    Determining the impact of 24/7 phone support on hospital readmissions after aortic valve replacement surgery (the AVRre study): study protocol for a randomised controlled trial
    Trials, 18 (1), 246
    DOI 10.1186/s13063-017-1971-y, PubMed 28693599
  14. Laake K, Seljeflot I, Schmidt EB, Myhre P, Tveit A, Norseth J, Arnesen H, Solheim S (2017)
    Galectin-3, a marker of cardiac remodeling, is inversely related to serum levels of marine omega-3 fatty acids. A cross-sectional study
    JRSM Cardiovasc Dis, 6, 2048004017729984
    DOI 10.1177/2048004017729984, PubMed 28932392
  15. Mariampillai JE, Engeseth K, Kjeldsen SE, Grundvold I, Liestøl K, Erikssen G, Erikssen J, Bodegard J, Skretteberg PT (2017)
    Exercise systolic blood pressure at moderate workload predicts cardiovascular disease and mortality through 35 years of follow-up in healthy, middle-aged men
    Blood Press, 26 (4), 229-236
    DOI 10.1080/08037051.2017.1291276, PubMed 28276720
  16. Myhre PL, Stridsberg M, Linko R, Okkonen M, Nygård S, Christensen G, Pettilä V, Omland T, Røsjø H, FINNALI Study Group (2017)
    Circulating chromogranin B levels in patients with acute respiratory failure: data from the FINNALI Study
    Biomarkers, 22 (8), 775-781
    DOI 10.1080/1354750X.2016.1269200, PubMed 28049363
  17. Njerve IU, Åkra S, Weiss TW, Solheim S, Øvstebø R, Aass HCD, Byrkjeland R, Arnesen H, Seljeflot I (2017)
    A Double-Blinded Randomized Study Investigating a Possible Anti-Inflammatory Effect of Saxagliptin versus Placebo as Add-On Therapy in Patients with Both Type 2 Diabetes And Stable Coronary Artery Disease
    Mediators Inflamm, 2017, 5380638
    DOI 10.1155/2017/5380638, PubMed 28596642
  18. Opstad TB, Seljeflot I, Bøhmer E, Arnesen H, Halvorsen S (2017)
    MMP-9 and Its Regulators TIMP-1 and EMMPRIN in Patients with Acute ST-Elevation Myocardial Infarction: A NORDISTEMI Substudy
    Cardiology, 139 (1), 17-24
    DOI 10.1159/000481684, PubMed 29141241
  19. Prestgaard E, Hodnesdal C, Engeseth K, Erikssen J, Bodegård J, Liestøl K, Gjesdal K, Kjeldsen SE, Grundvold I, Berge E (2017)
    Long-term predictors of stroke in healthy middle-aged men
    Int J Stroke, 13 (3), 292-300
    DOI 10.1177/1747493017730760, PubMed 28929941
  20. Ritschel V, Shetelig C, Seljeflot I, Limalanathan S, Hoffmann P, Halvorsen S, Arnesen H, Eritsland J, Andersen GØ (2017)
    Evaluation of circulating levels of CCN2/connective tissue growth factor in patients with ST-elevation myocardial infarction
    Sci Rep, 7 (1), 11945
    DOI 10.1038/s41598-017-12372-w, PubMed 28931920
  21. Shetelig C, Limalanathan S, Eritsland J, Hoffmann P, Seljeflot I, Gran JM, Aukrust P, Ueland T, Andersen GØ (2017)
    Osteoprotegerin levels in ST-elevation myocardial infarction: Temporal profile and association with myocardial injury and left ventricular function
    PLoS One, 12 (3), e0173034
    DOI 10.1371/journal.pone.0173034, PubMed 28253327
  22. Warlo EMK, Pettersen AR, Arnesen H, Seljeflot I (2017)
    vWF/ADAMTS13 is associated with on-aspirin residual platelet reactivity and clinical outcome in patients with stable coronary artery disease
    Thromb J, 15, 28
    DOI 10.1186/s12959-017-0151-3, PubMed 29200971
  23. Wexels F, Dahl OE, Pripp AH, Seljeflot I (2017)
    Thrombin Generation in Patients With Suspected Venous Thromboembolism
    Clin Appl Thromb Hemost, 23 (5), 416-421
    DOI 10.1177/1076029617700999, PubMed 28335612

Publications 2016

  1. Abdelnoor M, Vengen ØA, Johansen O, Sandven I, Abdelnoor AM (2016)
    Latitude of the study place and age of the patient are associated with incidence of mediastinitis and microbiology in open-heart surgery: a systematic review and meta-analysis
    Clin Epidemiol, 8, 151-63
    DOI 10.2147/CLEP.S96107, PubMed 27330329
  2. Beitland S, Nakstad ER, Staer-Jensen H, Draegni T, Andersen GØ, Jacobsen D, Brunborg C, Waldum-Grevbo B, Sunde K (2016)
    Impact of acute kidney injury on patient outcome in out-of-hospital cardiac arrest: a prospective observational study
    Acta Anaesthesiol Scand, 60 (8), 1170-81
    DOI 10.1111/aas.12753, PubMed 27306254
  3. Beitland S, Waldum-Grevbo BE, Nakstad ER, Berg JP, Trøseid AS, Brusletto BS, Brunborg C, Andersen GØ, Sunde K (2016)
    Urine biomarkers give early prediction of acute kidney injury and outcome after out-of-hospital cardiac arrest
    Crit Care, 20 (1), 314
    DOI 10.1186/s13054-016-1503-2, PubMed 27716377
  4. Bliksøen M, Mariero LH, Torp MK, Baysa A, Ytrehus K, Haugen F, Seljeflot I, Vaage J, Valen G, Stensløkken KO (2016)
    Extracellular mtDNA activates NF-κB via toll-like receptor 9 and induces cell death in cardiomyocytes
    Basic Res Cardiol, 111 (4), 42
    DOI 10.1007/s00395-016-0553-6, PubMed 27164906
  5. Byrkjeland R, Stensæth KH, Anderssen S, Njerve IU, Arnesen H, Seljeflot I, Solheim S (2016)
    Effects of exercise training on carotid intima-media thickness in patients with type 2 diabetes and coronary artery disease. Influence of carotid plaques
    Cardiovasc Diabetol, 15, 13
    DOI 10.1186/s12933-016-0336-2, PubMed 26801098
  6. Chiva-Blanch G, Bratseth V, Ritschel V, Andersen GØ, Halvorsen S, Eritsland J, Arnesen H, Badimon L, Seljeflot I (2016)
    Monocyte-derived circulating microparticles (CD14+, CD14+/CD11b+ and CD14+/CD142+) are related to long-term prognosis for cardiovascular mortality in STEMI patients
    Int J Cardiol, 227, 876-881
    DOI 10.1016/j.ijcard.2016.11.302, PubMed 27915085
  7. De Caterina R, Husted S, Wallentin L, Andreotti F, Arnesen H, Bachmann F, Baigent C, Collet JP, Halvorsen S, Huber K, Jespersen J, Kristensen SD, Lip GY, Morais J, Rasmussen LH, Ricci F, Sibbing D, Siegbahn A, Storey RF, Ten Berg J, Verheugt FW, Weitz JI (2016)
    Oral anticoagulants in coronary heart disease (Section IV). Position paper of the ESC Working Group on Thrombosis - Task Force on Anticoagulants in Heart Disease
    Thromb Haemost, 115 (4), 685-711
    DOI 10.1160/TH15-09-0703, PubMed 26952877
  8. Engeseth K, Hodnesdal C, Grundvold I, Liestøl K, Gjesdal K, Kjeldsen SE, Erikssen JE, Bodegard J, Skretteberg PT (2016)
    Temporal Reduction in Chronotropic Index Predicts Risk of Cardiovascular Death Among Healthy Middle-Aged Men: a 28-Year Follow-Up Study
    J Am Heart Assoc, 5 (12)
    DOI 10.1161/JAHA.116.004555, PubMed 27881424
  9. Haissman JM, Haugaard AK, Knudsen A, Kristoffersen US, Seljeflot I, Pedersen KK, Lebech AM, Hasbak P, Kjær A, Ostrowski SR, Gerstoft J, Trøseid M, Nielsen SD (2016)
    Marker of Endothelial Dysfunction Asymmetric Dimethylarginine Is Elevated in HIV Infection but Not Associated With Subclinical Atherosclerosis
    J Acquir Immune Defic Syndr, 73 (5), 507-513
    DOI 10.1097/QAI.0000000000001148, PubMed 27509250
  10. Helseth R, Solheim S, Arnesen H, Seljeflot I, Opstad TB (2016)
    The Time Course of Markers of Neutrophil Extracellular Traps in Patients Undergoing Revascularisation for Acute Myocardial Infarction or Stable Angina Pectoris
    Mediators Inflamm, 2016, 2182358
    DOI 10.1155/2016/2182358, PubMed 28074081
  11. Horjen AW, Ulimoen SR, Enger S, Norseth J, Seljeflot I, Arnesen H, Tveit A (2016)
    Troponin I levels in permanent atrial fibrillation-impact of rate control and exercise testing
    BMC Cardiovasc Disord, 16, 79
    DOI 10.1186/s12872-016-0255-x, PubMed 27142292
  12. Laake K, Seljeflot I, Schmidt EB, Myhre P, Tveit A, Arnesen H, Solheim S (2016)
    Serum Fatty Acids, Traditional Risk Factors, and Comorbidity as Related to Myocardial Injury in an Elderly Population with Acute Myocardial Infarction
    J Lipids, 2016, 4945720
    DOI 10.1155/2016/4945720, PubMed 26989512
  13. Myhre PL, Ottesen AH, Okkonen M, Linko R, Stridsberg M, Nygård S, Christensen G, Pettilä V, Omland T, Røsjø H, FINNALI Laboratory Study Group (2016)
    Prognostic Value of Secretoneurin in Patients with Acute Respiratory Failure: Data from the FINNALI Study
    Clin Chem, 62 (10), 1380-9
    DOI 10.1373/clinchem.2016.258764, PubMed 27540029
  14. Myhre PL, Tiainen M, Pettilä V, Vaahersalo J, Hagve TA, Kurola J, Varpula T, Omland T, Røsjø H, FINNRESUSCI Laboratory Study Group (2016)
    NT-proBNP in patients with out-of-hospital cardiac arrest: Results from the FINNRESUSCI Study
    Resuscitation, 104, 12-8
    DOI 10.1016/j.resuscitation.2016.04.007, PubMed 27109503
  15. Neerland BE, Hall RJ, Seljeflot I, Frihagen F, MacLullich AM, Raeder J, Wyller TB, Watne LO (2016)
    Associations Between Delirium and Preoperative Cerebrospinal Fluid C-Reactive Protein, Interleukin-6, and Interleukin-6 Receptor in Individuals with Acute Hip Fracture
    J Am Geriatr Soc, 64 (7), 1456-63
    DOI 10.1111/jgs.14238, PubMed 27341529
  16. Njerve IU, Byrkjeland R, Arnesen H, Åkra S, Solheim S, Seljeflot I (2016)
    Effects of long-term exercise training on adipose tissue expression of fractalkine and MCP-1 in patients with type 2 diabetes and stable coronary artery disease: a substudy of a randomized controlled trial
    Diabetes Metab Syndr Obes, 9, 55-62
    DOI 10.2147/DMSO.S96299, PubMed 27042130
  17. Opstad TB, Arnesen H, Pettersen AÅ, Seljeflot I (2016)
    Combined Elevated Levels of the Proinflammatory Cytokines IL-18 and IL-12 Are Associated with Clinical Events in Patients with Coronary Artery Disease: An Observational Study
    Metab Syndr Relat Disord, 14 (5), 242-8
    DOI 10.1089/met.2015.0130, PubMed 27058587
  18. Opstad TB, Brusletto BS, Arnesen H, Pettersen AÅ, Seljeflot I (2016)
    Cigarette smoking represses expression of cytokine IL-12 and its regulator miR-21-An observational study in patients with coronary artery disease
    Immunobiology, 222 (2), 169-175
    DOI 10.1016/j.imbio.2016.10.007, PubMed 27765464
  19. Ritschel VN, Seljeflot I, Arnesen H, Halvorsen S, Eritsland J, Fagerland MW, Andersen GØ (2016)
    Circulating Levels of IL-6 Receptor and gp130 and Long-Term Clinical Outcomes in ST-Elevation Myocardial Infarction
    J Am Heart Assoc, 5 (6)
    DOI 10.1161/JAHA.115.003014, PubMed 27412895
  20. Santos-Gallego CG, Vahl TP, Goliasch G, Picatoste B, Arias T, Ishikawa K, Njerve IU, Sanz J, Narula J, Sengupta PP, Hajjar RJ, Fuster V, Badimon JJ (2016)
    Sphingosine-1-Phosphate Receptor Agonist Fingolimod Increases Myocardial Salvage and Decreases Adverse Postinfarction Left Ventricular Remodeling in a Porcine Model of Ischemia/Reperfusion
    Circulation, 133 (10), 954-66
    DOI 10.1161/CIRCULATIONAHA.115.012427, PubMed 26826180
  21. Tegn N, Abdelnoor M, Aaberge L, Endresen K, Bendz B (2016)
    Invasive strategy in acute coronary syndrome - Authors' reply
    Lancet, 387 (10037), 2504
    DOI 10.1016/S0140-6736(16)30673-0, PubMed 27353680
  22. Tegn N, Abdelnoor M, Aaberge L, Endresen K, Smith P, Aakhus S, Gjertsen E, Dahl-Hofseth O, Ranhoff AH, Gullestad L, Bendz B, After Eighty study investigators (2016)
    Invasive versus conservative strategy in patients aged 80 years or older with non-ST-elevation myocardial infarction or unstable angina pectoris (After Eighty study): an open-label randomised controlled trial
    Lancet, 387 (10023), 1057-1065
    DOI 10.1016/S0140-6736(15)01166-6, PubMed 26794722
  23. Wexels F, Seljeflot I, Pripp AH, Dahl OE (2016)
    D-Dimer and prothrombin fragment 1 + 2 in urine and plasma in patients with clinically suspected venous thromboembolism
    Blood Coagul Fibrinolysis, 27 (4), 396-400
    DOI 10.1097/MBC.0000000000000461, PubMed 26595215

Publications 2015

  1. Andric T, Weiss TW, Huber K, Arnesen H, Seljeflot I (2015)
    Effects of diet and/or n-3 fatty acid supplementation on components of the interleukin-6 trans-signalling system in elderly men
    Scand J Clin Lab Invest, 75 (8), 646-51
    DOI 10.3109/00365513.2015.1063002, PubMed 26179891
  2. Berg IJ, van der Heijde D, Dagfinrud H, Seljeflot I, Olsen IC, Kvien TK, Semb AG, Provan SA (2015)
    Disease activity in ankylosing spondylitis and associations to markers of vascular pathology and traditional cardiovascular disease risk factors: a cross-sectional study
    J Rheumatol, 42 (4), 645-53
    DOI 10.3899/jrheum.141018, PubMed 25641897
  3. Bethke A, Halvorsen S, Bøhmer E, Abdelnoor M, Arnesen H, Hoffmann P (2015)
    Myocardial perfusion grade predicts final infarct size and left ventricular function in patients with ST-elevation myocardial infarction treated with a pharmaco-invasive strategy (thrombolysis and early angioplasty)
    EuroIntervention, 11 (5), 518-24
    DOI 10.4244/EIJY15M04_02, PubMed 25868877
  4. Byrkjeland R, Njerve IU, Anderssen S, Arnesen H, Seljeflot I, Solheim S (2015)
    Effects of exercise training on HbA1c and VO2peak in patients with type 2 diabetes and coronary artery disease: A randomised clinical trial
    Diab Vasc Dis Res, 12 (5), 325-33
    DOI 10.1177/1479164115590552, PubMed 26092822
  5. Dudek D, Siudak Z, Solheim S (2015)
    New model of secondary cardiovascular prevention for patients after acute coronary syndromes in Poland with regard to Norwegian experiences
    Kardiol Pol, 74 (2), 101-3
    DOI 10.5603/KP.a2015.0176, PubMed 26365935
  6. Ellingsen DG, Ulvestad B, Bakke B, Seljeflot I, Barregard L, Thomassen Y (2015)
    Serum pneumoproteins in tunnel construction workers
    Int Arch Occup Environ Health, 88 (7), 943-51
    DOI 10.1007/s00420-015-1023-4, PubMed 25632885
  7. Gjesdal K, Grundvold I (2015)
    Atrial fibrillation and exercise in women: some answers given, some questions remain
    Heart, 101 (20), 1605-6
    DOI 10.1136/heartjnl-2015-307836, PubMed 26206848
  8. Grundvold I, Bodegard J, Nilsson PM, Svennblad B, Johansson G, Östgren CJ, Sundström J (2015)
    Body weight and risk of atrial fibrillation in 7,169 patients with newly diagnosed type 2 diabetes; an observational study
    Cardiovasc Diabetol, 14, 5
    DOI 10.1186/s12933-014-0170-3, PubMed 25589001
  9. Halvorsen B, Espeland MZ, Andersen GØ, Yndestad A, Sagen EL, Rashidi A, Knudsen EC, Skjelland M, Skagen KR, Krohg-Sørensen K, Holm S, Ritschel V, Holven KB, Biessen EA, Aukrust P, Dahl TB (2015)
    Increased expression of NAMPT in PBMC from patients with acute coronary syndrome and in inflammatory M1 macrophages
    Atherosclerosis, 243 (1), 204-10
    DOI 10.1016/j.atherosclerosis.2015.09.010, PubMed 26402139
  10. Hansen CH, Ritschel V, Halvorsen S, Andersen GØ, Bjørnerheim R, Eritsland J, Arnesen H, Seljeflot I (2015)
    Markers of thrombin generation are associated with myocardial necrosis and left ventricular impairment in patients with ST-elevation myocardial infarction
    Thromb J, 13, 31
    DOI 10.1186/s12959-015-0061-1, PubMed 26396552
  11. Heier M, Margeirsdottir HD, Gaarder M, Stensæth KH, Brunborg C, Torjesen PA, Seljeflot I, Hanssen KF, Dahl-Jørgensen K (2015)
    Soluble RAGE and atherosclerosis in youth with type 1 diabetes: a 5-year follow-up study
    Cardiovasc Diabetol, 14, 126
    DOI 10.1186/s12933-015-0292-2, PubMed 26408307
  12. Heier M, Margeirsdottir HD, Torjesen PA, Seljeflot I, Stensæth KH, Gaarder M, Brunborg C, Hanssen KF, Dahl-Jørgensen K (2015)
    The advanced glycation end product methylglyoxal-derived hydroimidazolone-1 and early signs of atherosclerosis in childhood diabetes
    Diab Vasc Dis Res, 12 (2), 139-45
    DOI 10.1177/1479164114560910, PubMed 25616705
  13. Helseth R, Opstad T, Solheim S, Lunde K, Arnesen H, Seljeflot I (2015)
    The Effect of Intracoronary Stem Cell Injection on Markers of Leukocyte Activation in Acute Myocardial Infarction
    Cardiol Res, 6 (1), 209-215
    DOI 10.14740/cr375w, PubMed 28197227
  14. Helseth R, Weiss TW, Opstad TB, Siegbahn A, Solheim S, Freynhofer MK, Huber K, Arnesen H, Seljeflot S (2015)
    Associations between circulating proteins and corresponding genes expressed in coronary thrombi in patients with acute myocardial infarction
    Thromb Res, 136 (6), 1240-4
    DOI 10.1016/j.thromres.2015.10.005, PubMed 26475405
  15. Horjen AW, Ulimoen SR, Seljeflot I, Smith P, Arnesen H, Norseth J, Tveit A (2015)
    High-Sensitivity Troponin I and Rhythm Outcome after Electrical Cardioversion for Persistent Atrial Fibrillation
    Cardiology, 133 (4), 233-8
    DOI 10.1159/000442249, PubMed 26697854
  16. Lindholm EE, Aune E, Seljeflot I, Otterstad JE, Kirkebøen KA (2015)
    Biomarkers of inflammation in major vascular surgery: a prospective randomised trial
    Acta Anaesthesiol Scand, 59 (6), 773-87
    DOI 10.1111/aas.12466, PubMed 25626738
  17. Laake K, Seljeflot I, Fagerland MW, Njerve IU, Arnesen H, Solheim S (2015)
    Effects on serum fractalkine by diet and omega-3 fatty acid intervention: relation to clinical outcome
    Mediators Inflamm, 2015, 373070
    DOI 10.1155/2015/373070, PubMed 25733777
  18. Pettersen AA, Arnesen H, Seljeflot I (2015)
    A brief review on high on-aspirin residual platelet reactivity
    Vascul Pharmacol, 67-69, 6-9
    DOI 10.1016/j.vph.2015.03.018, PubMed 25869498
  19. Skrede K, Wyller TB, Watne LO, Seljeflot I, Juliebø V (2015)
    Is there a role for monocyte chemoattractant protein-1 in delirium? Novel observations in elderly hip fracture patients
    BMC Res Notes, 8, 186
    DOI 10.1186/s13104-015-1129-5, PubMed 25943983
  20. Stær-Jensen H, Nakstad ER, Fossum E, Mangschau A, Eritsland J, Drægni T, Jacobsen D, Sunde K, Andersen GØ (2015)
    Post-Resuscitation ECG for Selection of Patients for Immediate Coronary Angiography in Out-of-Hospital Cardiac Arrest
    Circ Cardiovasc Interv, 8 (10)
    DOI 10.1161/CIRCINTERVENTIONS.115.002784, PubMed 26453688
  21. Stær-Jensen H, Sunde K, Andersen GØ (2015)
    The authors reply
    Crit Care Med, 43 (3), e98
    DOI 10.1097/CCM.0000000000000812, PubMed 25700077
  22. Sunde K, Andersen GØ (2015)
    Prediction of outcome after out-of-hospital cardiac arrest already on hospital admission-not reliable enough to be true!
    Eur Heart J, 37 (42), 3229-3231
    DOI 10.1093/eurheartj/ehv490, PubMed 26516178
  23. Trøseid M, Nestvold TK, Nielsen EW, Thoresen H, Seljeflot I, Lappegård KT (2015)
    Soluble CD14 is associated with markers of vascular dysfunction in bariatric surgery patients
    Metab Syndr Relat Disord, 13 (3), 119-24
    DOI 10.1089/met.2014.0111, PubMed 25562385
  24. Ørstavik Ø, Manfra O, Andressen KW, Andersen GØ, Skomedal T, Osnes JB, Levy FO, Krobert KA (2015)
    The inotropic effect of the active metabolite of levosimendan, OR-1896, is mediated through inhibition of PDE3 in rat ventricular myocardium
    PLoS One, 10 (3), e0115547
    DOI 10.1371/journal.pone.0115547, PubMed 25738589

Publications 2014

  1. Abdelnoor M, Sandven I, Limalanathan S, Eritsland J (2014)
    Postconditioning in ST-elevation myocardial infarction: a systematic review, critical appraisal, and meta-analysis of randomized clinical trials
    Vasc Health Risk Manag, 10, 477-91
    DOI 10.2147/VHRM.S67154, PubMed 25143742
  2. Andersen GØ (2014)
    Circulatory shock
    N Engl J Med, 370 (6), 583
    DOI 10.1056/NEJMc1314999, PubMed 24499234
  3. Byrkjeland R, Edvardsen E, Njerve IU, Arnesen H, Seljeflot I, Solheim S (2014)
    Insulin levels and HOMA index are associated with exercise capacity in patients with type 2 diabetes and coronary artery disease
    Diabetol Metab Syndr, 6 (1), 36
    DOI 10.1186/1758-5996-6-36, PubMed 24612649
  4. Bøhmer E, Kristiansen IS, Arnesen H, Halvorsen S (2014)
    Health-related quality of life after myocardial infarction, does choice of method make a difference?
    Scand Cardiovasc J, 48 (4), 216-22
    DOI 10.3109/14017431.2014.923581, PubMed 24828790
  5. Engeseth K, Hodnesdal C, Grundvold I, Liestøl K, Gjesdal K, Erikssen G, Kjeldsen SE, Erikssen JE, Bodegard J, Skretteberg PT (2014)
    Heart rate reserve predicts cardiovascular death among physically unfit but otherwise healthy middle-aged men: a 35-year follow-up study
    Eur J Prev Cardiol, 23 (1), 59-66
    DOI 10.1177/2047487314553202, PubMed 25281482
  6. Furenes EB, Opstad TB, Solheim S, Lunde K, Arnesen H, Seljeflot I (2014)
    The influence of autologous bone marrow stem cell transplantation on matrix metalloproteinases in patients treated for acute ST-elevation myocardial infarction
    Mediators Inflamm, 2014, 385901
    DOI 10.1155/2014/385901, PubMed 25294955
  7. Heier M, Margeirsdottir HD, Brunborg C, Hanssen KF, Dahl-Jørgensen K, Seljeflot I (2014)
    Inflammation in childhood type 1 diabetes; influence of glycemic control
    Atherosclerosis, 238 (1), 33-7
    DOI 10.1016/j.atherosclerosis.2014.11.018, PubMed 25437887
  8. Helseth R, Seljeflot I, Opstad T, Solheim S, Freynhofer M, Arnesen H, Huber K, Weiss T (2014)
    Genes expressed in coronary thrombi are associated with ischemic time in patients with acute myocardial infarction
    Thromb Res, 135 (2), 329-33
    DOI 10.1016/j.thromres.2014.11.028, PubMed 25496999
  9. Helseth R, Solheim S, Opstad T, Hoffmann P, Arnesen H, Seljeflot I (2014)
    The time profile of Pentraxin 3 in patients with acute ST-elevation myocardial infarction and stable angina pectoris undergoing percutaneous coronary intervention
    Mediators Inflamm, 2014, 608414
    DOI 10.1155/2014/608414, PubMed 24737925
  10. Husebye T, Eritsland J, Arnesen H, Bjørnerheim R, Mangschau A, Seljeflot I, Andersen GØ (2014)
    Association of interleukin 8 and myocardial recovery in patients with ST-elevation myocardial infarction complicated by acute heart failure
    PLoS One, 9 (11), e112359
    DOI 10.1371/journal.pone.0112359, PubMed 25390695
  11. Husted S, de Caterina R, Andreotti F, Arnesen H, Bachmann F, Huber K, Jespersen J, Kristensen SD, Lip GY, Morais J, Rasmussen LH, Siegbahn A, Storey RF, Weitz JI, ESC Working Group on Thrombosis Task Force on Anticoagulants in Heart Disease (2014)
    Non-vitamin K antagonist oral anticoagulants (NOACs): No longer new or novel
    Thromb Haemost, 111 (5), 781-2
    DOI 10.1160/TH14-03-0228, PubMed 24658395
  12. Limalanathan S, Andersen GØ, Kløw NE, Abdelnoor M, Hoffmann P, Eritsland J (2014)
    Effect of ischemic postconditioning on infarct size in patients with ST-elevation myocardial infarction treated by primary PCI results of the POSTEMI (POstconditioning in ST-Elevation Myocardial Infarction) randomized trial
    J Am Heart Assoc, 3 (2), e000679
    DOI 10.1161/JAHA.113.000679, PubMed 24760962
  13. Laake K, Myhre P, Nordby LM, Seljeflot I, Abdelnoor M, Smith P, Tveit A, Arnesen H, Solheim S (2014)
    Effects of ω3 supplementation in elderly patients with acute myocardial infarction: design of a prospective randomized placebo controlled study
    BMC Geriatr, 14, 74
    DOI 10.1186/1471-2318-14-74, PubMed 24928284
  14. Njerve IU, Solheim S, Lunde K, Hoffmann P, Arnesen H, Seljeflot I (2014)
    Fractalkine levels are elevated early after PCI-treated ST-elevation myocardial infarction; no influence of autologous bone marrow derived stem cell injection
    Cytokine, 69 (1), 131-5
    DOI 10.1016/j.cyto.2014.05.022, PubMed 24930044
  15. Opstad TB, Arnesen H, Pettersen AÅ, Seljeflot I (2014)
    The MMP-9 -1562 C/T polymorphism in the presence of metabolic syndrome increases the risk of clinical events in patients with coronary artery disease
    PLoS One, 9 (9), e106816
    DOI 10.1371/journal.pone.0106816, PubMed 25191702
  16. Orstavik O, Ata SH, Riise J, Dahl CP, Andersen GØ, Levy FO, Skomedal T, Osnes JB, Qvigstad E (2014)
    Inhibition of phosphodiesterase-3 by levosimendan is sufficient to account for its inotropic effect in failing human heart
    Br J Pharmacol, 171 (23), 5169-81
    DOI 10.1111/bph.12647, PubMed 24547784
  17. Pedersen KK, Manner IW, Seljeflot I, Kvale D, Os I, Gerstoft J, Nielsen SD, Trøseid M (2014)
    Monocyte activation, but not microbial translocation, is independently associated with markers of endovascular dysfunction in HIV-infected patients receiving cART
    J Acquir Immune Defic Syndr, 67 (4), 370-4
    DOI 10.1097/QAI.0000000000000339, PubMed 25226210
  18. Stær-Jensen H, Sunde K, Olasveengen TM, Jacobsen D, Drægni T, Nakstad ER, Eritsland J, Andersen GØ (2014)
    Bradycardia during therapeutic hypothermia is associated with good neurologic outcome in comatose survivors of out-of-hospital cardiac arrest
    Crit Care Med, 42 (11), 2401-8
    DOI 10.1097/CCM.0000000000000515, PubMed 25072762
  19. Sveen KA, Dahl-Jørgensen K, Stensaeth KH, Angel K, Seljeflot I, Sell DR, Monnier VM, Hanssen KF (2014)
    Glucosepane and oxidative markers in skin collagen correlate with intima media thickness and arterial stiffness in long-term type 1 diabetes
    J Diabetes Complications, 29 (3), 407-12
    DOI 10.1016/j.jdiacomp.2014.12.011, PubMed 25600701
  20. Svendsen M, Tonstad S, Heggen E, Pedersen TR, Seljeflot I, Bøhn SK, Bastani NE, Blomhoff R, Holme IM, Klemsdal TO (2014)
    The effect of kiwifruit consumption on blood pressure in subjects with moderately elevated blood pressure: a randomized, controlled study
    Blood Press, 24 (1), 48-54
    DOI 10.3109/08037051.2014.976979, PubMed 25483553
  21. Ulimoen SR, Enger S, Norseth J, Pripp AH, Abdelnoor M, Arnesen H, Gjesdal K, Tveit A (2014)
    Improved rate control reduces cardiac troponin T levels in permanent atrial fibrillation
    Clin Cardiol, 37 (7), 422-7
    DOI 10.1002/clc.22281, PubMed 24700386
  22. Wexels F, Dahl OE, Pripp AH, Seljeflot I, Borris LC, Haslund A, Gudmundsen TE, Lauritzen T, Lassen MR (2014)
    Prothrombin fragment 1+2 in urine as a marker on coagulation activity in patients with suspected pulmonary embolism
    Thromb Res, 134 (1), 68-71
    DOI 10.1016/j.thromres.2014.04.011, PubMed 24824294
  23. Wonnerth A, Katsaros KM, Krychtiuk KA, Speidl WS, Kaun C, Thaler K, Huber K, Wojta J, Maurer G, Seljeflot I, Arnesen H, Weiss TW (2014)
    Glycoprotein 130 polymorphism predicts soluble glycoprotein 130 levels
    Metabolism, 63 (5), 647-53
    DOI 10.1016/j.metabol.2014.02.005, PubMed 24629561

Publications 2013

  1. Arnesen H, Seljeflot I (2013)
    The challenge of judging data on the effects of N-3 fatty acids in CHD
    Scand Cardiovasc J, 47 (2), 67-8
    DOI 10.3109/14017431.2012.761348, PubMed 23327650
  2. Berge T, Ulimoen SR, Enger S, Arnesen H, Seljeflot I, Tveit A (2013)
    Impact of atrial fibrillation on inflammatory and fibrinolytic variables in the elderly
    Scand J Clin Lab Invest, 73 (4), 326-33
    DOI 10.3109/00365513.2013.780093, PubMed 23586783
  3. De Caterina R, Husted S, Wallentin L, Andreotti F, Arnesen H, Bachmann F, Baigent C, Huber K, Jespersen J, Kristensen SD, Lip GY, Morais J, Rasmussen LH, Siegbahn A, Verheugt FW, Weitz JI (2013)
    Vitamin K antagonists in heart disease: current status and perspectives (Section III). Position paper of the ESC Working Group on Thrombosis--Task Force on Anticoagulants in Heart Disease
    Thromb Haemost, 110 (6), 1087-107
    DOI 10.1160/TH13-06-0443, PubMed 24226379
  4. De Caterina R, Husted S, Wallentin L, Andreotti F, Arnesen H, Bachmann F, Baigent C, Huber K, Jespersen J, Kristensen SD, Lip GY, Morais J, Rasmussen LH, Siegbahn A, Verheugt FW, Weitz JI, European Society of Cardiology Working Group on Thrombosis Task Force on Anticoagulants in Heart Disease (2013)
    General mechanisms of coagulation and targets of anticoagulants (Section I). Position Paper of the ESC Working Group on Thrombosis--Task Force on Anticoagulants in Heart Disease
    Thromb Haemost, 109 (4), 569-79
    DOI 10.1160/TH12-10-0772, PubMed 23447024
  5. De Caterina R, Husted S, Wallentin L, Andreotti F, Arnesen H, Bachmann F, Baigent C, Huber K, Jespersen J, Kristensen SD, Lip GY, Morais J, Rasmussen LH, Siegbahn A, Verheugt FW, Weitz JI, European Society of Cardiology Working Group on Thrombosis Task Force on Anticoagulants in Heart Disease (2013)
    Parenteral anticoagulants in heart disease: current status and perspectives (Section II). Position paper of the ESC Working Group on Thrombosis-Task Force on Anticoagulants in Heart Disease
    Thromb Haemost, 109 (5), 769-86
    DOI 10.1160/TH12-06-0403, PubMed 23636477
  6. Grundvold I, Skretteberg PT, Engeseth K, Gjesdal K, Kjeldsen SE, Arnesen H, Bodegard J, Liestøl K, Erikssen G, Erikssen J (2013)
    Response to Letter by Morris et al regarding article, "Low heart rates predict incident atrial fibrillation in healthy middle-aged men" by Grundvold et al
    Circ Arrhythm Electrophysiol, 6 (6), e102
    DOI 10.1161/CIRCEP.113.001154, PubMed 24347602
  7. Grundvold I, Skretteberg PT, Liestøl K, Erikssen G, Engeseth K, Gjesdal K, Kjeldsen SE, Arnesen H, Erikssen J, Bodegard J (2013)
    Low heart rates predict incident atrial fibrillation in healthy middle-aged men
    Circ Arrhythm Electrophysiol, 6 (4), 726-31
    DOI 10.1161/CIRCEP.113.000267, PubMed 23873309
  8. Hopp E, Bjørnerud A, Lunde K, Solheim S, Aakhus S, Arnesen H, Forfang K, Edvardsen T, Smith HJ (2013)
    Perfusion MRI at rest in subacute and chronic myocardial infarct
    Acta Radiol, 54 (4), 401-11
    DOI 10.1177/0284185113475605, PubMed 23401603
  9. Husebye T, Eritsland J, Müller C, Sandvik L, Arnesen H, Seljeflot I, Mangschau A, Bjørnerheim R, Andersen GØ (2013)
    Levosimendan in acute heart failure following primary percutaneous coronary intervention-treated acute ST-elevation myocardial infarction. Results from the LEAF trial: a randomized, placebo-controlled study
    Eur J Heart Fail, 15 (5), 565-72
    DOI 10.1093/eurjhf/hfs215, PubMed 23288914
  10. Limalanathan S, Eritsland J, Andersen GØ, Kløw NE, Abdelnoor M, Hoffmann P (2013)
    Myocardial salvage is reduced in primary PCI-treated STEMI patients with microvascular obstruction, demonstrated by early and late CMR
    PLoS One, 8 (8), e71780
    DOI 10.1371/journal.pone.0071780, PubMed 23977143
  11. Opstad TB, Pettersen AÅ, Arnesen H, Seljeflot I (2013)
    The co-existence of the IL-18+183 A/G and MMP-9 -1562 C/T polymorphisms is associated with clinical events in coronary artery disease patients
    PLoS One, 8 (9), e74498
    DOI 10.1371/journal.pone.0074498, PubMed 24040261
  12. Ritschel VN, Seljeflot I, Arnesen H, Halvorsen S, Weiss T, Eritsland J, Andersen GØ (2013)
    IL-6 signalling in patients with acute ST-elevation myocardial infarction
    Results Immunol, 4, 8-13
    DOI 10.1016/j.rinim.2013.11.002, PubMed 24707455
  13. Rohla M, Freynhofer MK, Hammerl H, Weiss TW, Huber K (2013)
    Stroke and recurrent left atrial appendage thrombus in a patient with atrial fibrillation under old and new oral anticoagulants: a case report
    Thromb Haemost, 111 (2), 375-8
    DOI 10.1160/TH13-06-0446, PubMed 24136295
  14. Rohla M, Freynhofer MK, Tentzeris I, Farhan S, Wojta J, Huber K, Weiss TW (2013)
    Plasma osmolality predicts clinical outcome in patients with acute coronary syndrome undergoing percutaneous coronary intervention
    Eur Heart J Acute Cardiovasc Care, 3 (1), 84-92
    DOI 10.1177/2048872613516018, PubMed 24337920
  15. Rønning B, Wyller TB, Jordhøy MS, Nesbakken A, Bakka A, Seljeflot I, Kristjansson SR (2013)
    Frailty indicators and functional status in older patients after colorectal cancer surgery
    J Geriatr Oncol, 5 (1), 26-32
    DOI 10.1016/j.jgo.2013.08.001, PubMed 24484715
  16. Skretteberg PT, Grundvold I, Kjeldsen SE, Engeseth K, Liestøl K, Erikssen G, Erikssen J, Gjesdal K, Bodegard J (2013)
    Seven-year increase in exercise systolic blood pressure at moderate workload predicts long-term risk of coronary heart disease and mortality in healthy middle-aged men
    Hypertension, 61 (5), 1134-40
    DOI 10.1161/HYPERTENSIONAHA.111.00793, PubMed 23529164
  17. Skretteberg PT, Grytten AN, Gjertsen K, Grundvold I, Kjeldsen SE, Erikssen J, Mellbin L, Liestøl K, Fraser DA, Erikssen G, Pedersen TR, Bodegard J (2013)
    Triglycerides-diabetes association in healthy middle-aged men: modified by physical fitness? A long term follow-up of 1962 Norwegian men in the Oslo Ischemia Study
    Diabetes Res Clin Pract, 101 (2), 201-9
    DOI 10.1016/j.diabres.2013.06.001, PubMed 23827210
  18. Solheim S, Seljeflot I, Lunde K, Bratseth V, Aakhus S, Forfang K, Arnesen H (2013)
    Prothrombotic markers in patients with acute myocardial infarction and left ventricular thrombus formation treated with pci and dual antiplatelet therapy
    Thromb J, 11 (1), 1
    DOI 10.1186/1477-9560-11-1, PubMed 23311309
  19. Tveit A, Seljeflot I, Smith P, Arnesen H, Svendsen JH (2013)
    Angiotensin II blockade, YKL-40 and maintenance of sinus rhythm after electrical cardioversion for atrial fibrillation
    Immunobiology, 218 (10), 1256-60
    DOI 10.1016/j.imbio.2013.04.014, PubMed 23731775
  20. Ulimoen SR, Enger S, Pripp AH, Abdelnoor M, Arnesen H, Gjesdal K, Tveit A (2013)
    Calcium channel blockers improve exercise capacity and reduce N-terminal Pro-B-type natriuretic peptide levels compared with beta-blockers in patients with permanent atrial fibrillation
    Eur Heart J, 35 (8), 517-24
    DOI 10.1093/eurheartj/eht429, PubMed 24135831
  21. Vengen OA, Abdelnoor M, Westheim AS, Smith G, Fjeld NB (2013)
    Outcome of mitral valve plasty or replacement: atrial fibrillation an effect modifier
    J Cardiothorac Surg, 8, 142
    DOI 10.1186/1749-8090-8-142, PubMed 23724788
  22. Weiss TW, Arnesen H, Seljeflot I (2013)
    Components of the interleukin-6 transsignalling system are associated with the metabolic syndrome, endothelial dysfunction and arterial stiffness
    Metabolism, 62 (7), 1008-13
    DOI 10.1016/j.metabol.2013.01.019, PubMed 23428306
  23. Wexels F, Haslund A, Dahl OE, Pripp AH, Gudmundsen TE, Laszlo F, Seljeflot I, Borris LC, Lassen MR (2013)
    Thrombin split products (prothrombin fragment 1 + 2) in urine in patients with suspected deep vein thrombosis admitted for radiological verification
    Thromb Res, 131 (6), 560-3
    DOI 10.1016/j.thromres.2013.04.019, PubMed 23680105

Publications 2012

  1. Abdelnoor M, Eritsland J, Brunborg C, Halvorsen S (2012)
    Ethnicity and acute myocardial infarction: risk profile at presentation, access to hospital management, and outcome in Norway
    Vasc Health Risk Manag, 8, 505-15
    DOI 10.2147/VHRM.S33627, PubMed 22956878
  2. Angel K, Provan SA, Mowinckel P, Seljeflot I, Kvien TK, Atar D (2012)
    The L-arginine/asymmetric dimethylarginine ratio is improved by anti-tumor necrosis factor-α therapy in inflammatory arthropathies. Associations with aortic stiffness
    Atherosclerosis, 225 (1), 160-5
    DOI 10.1016/j.atherosclerosis.2012.08.033, PubMed 23014354
  3. Bliksøen M, Mariero LH, Ohm IK, Haugen F, Yndestad A, Solheim S, Seljeflot I, Ranheim T, Andersen GØ, Aukrust P, Valen G, Vinge LE (2012)
    Increased circulating mitochondrial DNA after myocardial infarction
    Int J Cardiol, 158 (1), 132-4
    DOI 10.1016/j.ijcard.2012.04.047, PubMed 22578950
  4. Bratseth V, Pettersen AÅ, Opstad TB, Arnesen H, Seljeflot I (2012)
    Markers of hypercoagulability in CAD patients. Effects of single aspirin and clopidogrel treatment
    Thromb J, 10 (1), 12
    DOI 10.1186/1477-9560-10-12, PubMed 22883224
  5. De Caterina R, Husted S, Wallentin L, Andreotti F, Arnesen H, Bachmann F, Baigent C, Huber K, Jespersen J, Kristensen SD, Lip GY, Morais J, Rasmussen LH, Siegbahn A, Verheugt FW, Weitz JI, Coordinating Committee (2012)
    New oral anticoagulants in atrial fibrillation and acute coronary syndromes: ESC Working Group on Thrombosis-Task Force on Anticoagulants in Heart Disease position paper
    J Am Coll Cardiol, 59 (16), 1413-25
    DOI 10.1016/j.jacc.2012.02.008, PubMed 22497820
  6. Fraser DA, Diep LM, Hovden IA, Nilsen KB, Sveen KA, Seljeflot I, Hanssen KF (2012)
    Response to Comment on: Fraser et al. The Effects of Long-Term Oral Benfotiamine Supplementation on Peripheral Nerve Function and Inflammatory Markers in Patients With Type 1 Diabetes: A 24-Month, Double-Blind, Randomized, Placebo-Controlled Trial. Diabetes Care 2012;35:1095-1097
    Diabetes Care, 35 (11), E80
  7. Fraser DA, Diep LM, Hovden IA, Nilsen KB, Sveen KA, Seljeflot I, Hanssen KF (2012)
    The effects of long-term oral benfotiamine supplementation on peripheral nerve function and inflammatory markers in patients with type 1 diabetes: a 24-month, double-blind, randomized, placebo-controlled trial
    Diabetes Care, 35 (5), 1095-7
    DOI 10.2337/dc11-1895, PubMed 22446172
  8. Grundvold I, Skretteberg PT, Liestøl K, Erikssen G, Kjeldsen SE, Arnesen H, Erikssen J, Bodegard J (2012)
    Upper normal blood pressures predict incident atrial fibrillation in healthy middle-aged men: a 35-year follow-up study
    Hypertension, 59 (2), 198-204
    DOI 10.1161/HYPERTENSIONAHA.111.179713, PubMed 22252392
  9. Grundvold I, Skretteberg PT, Liestøl K, Gjesdal K, Erikssen G, Kjeldsen SE, Arnesen H, Erikssen J, Bodegard J (2012)
    Importance of physical fitness on predictive effect of body mass index and weight gain on incident atrial fibrillation in healthy middle-age men
    Am J Cardiol, 110 (3), 425-32
    DOI 10.1016/j.amjcard.2012.03.043, PubMed 22579085
  10. Halvorsen S (2012)
    STEMI treatment in areas remote from primary PCI centres
    EuroIntervention, 8 Suppl P, P44-50
    DOI 10.4244/EIJV8SPA8, PubMed 22917789
  11. Halvorsen S, Seljeflot I, Weiss T, Bøhmer E, Arnesen H (2012)
    Inflammatory and thrombotic markers in patients with ST-elevation myocardial infarction treated with thrombolysis and early PCI: a NORDISTEMI substudy
    Thromb Res, 130 (3), 495-500
    DOI 10.1016/j.thromres.2012.04.016, PubMed 22607887
  12. Hassellund SS, Flaa A, Kjeldsen SE, Seljeflot I, Karlsen A, Erlund I, Rostrup M (2012)
    Effects of anthocyanins on cardiovascular risk factors and inflammation in pre-hypertensive men: a double-blind randomized placebo-controlled crossover study
    J Hum Hypertens, 27 (2), 100-6
    DOI 10.1038/jhh.2012.4, PubMed 22336903
  13. Karlsen A, Svendsen M, Seljeflot I, Laake P, Duttaroy AK, Drevon CA, Arnesen H, Tonstad S, Blomhoff R (2012)
    Kiwifruit decreases blood pressure and whole-blood platelet aggregation in male smokers
    J Hum Hypertens, 27 (2), 126-30
    DOI 10.1038/jhh.2011.116, PubMed 22258209
  14. Lie I, Bunch EH, Smeby NA, Arnesen H, Hamilton G (2012)
    Patients' experiences with symptoms and needs in the early rehabilitation phase after coronary artery bypass grafting
    Eur J Cardiovasc Nurs, 11 (1), 14-24
    DOI 10.1016/j.ejcnurse.2010.09.004, PubMed 21030311
  15. Lindholm E, Seljeflot I, Aune E, Kirkebøen KA (2012)
    Proinflammatory cytokines and complement activation in salvaged blood from abdominal aortic aneurism surgery and total hip replacement surgery
    Transfusion, 52 (8), 1761-9
    DOI 10.1111/j.1537-2995.2011.03528.x, PubMed 22304534
  16. Njerve IU, Pettersen AÅ, Opstad TB, Arnesen H, Seljeflot I (2012)
    Fractalkine and its receptor (CX3CR1) in patients with stable coronary artery disease and diabetes mellitus
    Metab Syndr Relat Disord, 10 (6), 400-6
    DOI 10.1089/met.2012.0052, PubMed 22897138
  17. Pettersen AÅ, Arnesen H, Opstad TB, Bratseth V, Seljeflot I (2012)
    Markers of endothelial and platelet activation are associated with high on-aspirin platelet reactivity in patients with stable coronary artery disease
    Thromb Res, 130 (3), 424-8
    DOI 10.1016/j.thromres.2012.06.016, PubMed 22795340
  18. Pettersen AÅ, Seljeflot I, Abdelnoor M, Arnesen H (2012)
    High On-Aspirin Platelet Reactivity and Clinical Outcome in Patients With Stable Coronary Artery Disease: Results From ASCET (Aspirin Nonresponsiveness and Clopidogrel Endpoint Trial)
    J Am Heart Assoc, 1 (3), e000703
    DOI 10.1161/JAHA.112.000703, PubMed 23130135
  19. Prendergast B, Coope LT, Crijns H, Falkenstein E, Fölsch U, Halvorsen S, Janssens S, Jokinen E, Kroemer HK, Lücke A, Murer H, Nagel E, Neyses L, Perk J, Probst-Hensch N, Rietschel ET, Rütten H, Steingen C, Tedgui A, van Gilst W, Eschenhagen T, Kristensen SD (2012)
    The German Centre for Cardiovascular Research
    Eur Heart J, 33 (9), 1033-36,1036a
    PubMed 22893891
  20. Seljeflot I (2012)
    Plasma asymmetric dimethylarginine in patients with acute decompensation of chronic heart failure
    Heart, 98 (11), 831-2
    DOI 10.1136/heartjnl-2012-301932, PubMed 22581731
  21. Seljeflot I, R Ulimoen S, Enger S, Bratseth V, Arnesen H, Tveit A (2012)
    Asymmetric Dimethylarginine Levels are Highly Associated With Atrial Fibrillation in an Elderly Population
    Cardiol Res, 3 (3), 109-115
    DOI 10.4021/cr175w, PubMed 28352406
  22. Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC), Steg PG, James SK, Atar D, Badano LP, Blömstrom-Lundqvist C, Borger MA, Di Mario C, Dickstein K, Ducrocq G, Fernandez-Aviles F, Gershlick AH, Giannuzzi P, Halvorsen S, Huber K, Juni P, Kastrati A, Knuuti J, Lenzen MJ, Mahaffey KW, Valgimigli M, van 't Hof A, Widimsky P, Zahger D (2012)
    ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation
    Eur Heart J, 33 (20), 2569-619
    DOI 10.1093/eurheartj/ehs215, PubMed 22922416
  23. Ulimoen SR, Enger S, Carlson J, Platonov PG, Pripp AH, Abdelnoor M, Arnesen H, Gjesdal K, Tveit A (2012)
    Comparison of four single-drug regimens on ventricular rate and arrhythmia-related symptoms in patients with permanent atrial fibrillation
    Am J Cardiol, 111 (2), 225-30
    DOI 10.1016/j.amjcard.2012.09.020, PubMed 23111138
  24. Wisløff T, Selmer RM, Halvorsen S, Fretheim A, Norheim OF, Kristiansen IS (2012)
    Choice of generic antihypertensive drugs for the primary prevention of cardiovascular disease--a cost-effectiveness analysis
    BMC Cardiovasc Disord, 12, 26
    DOI 10.1186/1471-2261-12-26, PubMed 22475076

Publications 2011

  1. Andersen GØ, Knudsen EC, Aukrust P, Yndestad A, Oie E, Müller C, Seljeflot I, Ueland T (2011)
    Elevated serum osteoprotegerin levels measured early after acute ST-elevation myocardial infarction predict final infarct size
    Heart, 97 (6), 460-5
    DOI 10.1136/hrt.2010.206714, PubMed 21270073
  2. Andersen GØ, Ueland T, Knudsen EC, Scholz H, Yndestad A, Sahraoui A, Smith C, Lekva T, Otterdal K, Halvorsen B, Seljeflot I, Aukrust P (2011)
    Activin A levels are associated with abnormal glucose regulation in patients with myocardial infarction: potential counteracting effects of activin A on inflammation
    Diabetes, 60 (5), 1544-51
    DOI 10.2337/db10-1493, PubMed 21464440
  3. Bendz B, Endresen K, Eritsland J, Arnesen H (2011)
    [Don't withdraw all blood platelet inhibitors]
    Tidsskr Nor Laegeforen, 131 (8), 800; author reply 800
    DOI 10.4045/tidsskr.11.0278, PubMed 21556070
  4. Byrkjeland R, Nilsson BB, Westheim AS, Arnesen H, Seljeflot I (2011)
    Inflammatory markers as related to disease severity in patients with chronic heart failure: limited effects of exercise training
    Scand J Clin Lab Invest, 71 (7), 598-605
    DOI 10.3109/00365513.2011.598943, PubMed 21831004
  5. Bøhmer E, Kristiansen IS, Arnesen H, Halvorsen S (2011)
    Health and cost consequences of early versus late invasive strategy after thrombolysis for acute myocardial infarction
    Eur J Cardiovasc Prev Rehabil, 18 (5), 717-23
    DOI 10.1177/1741826711398425, PubMed 21450598
  6. Grimsmo J, Maehlum S, Moelstad P, Arnesen H (2011)
    Mortality and cardiovascular morbidity among long-term endurance male cross country skiers followed for 28-30 years
    Scand J Med Sci Sports, 21 (6), e351-8
    DOI 10.1111/j.1600-0838.2011.01307.x, PubMed 21477204
  7. Grøgaard HK, Solheim S, Landsverk KS, Seljeflot I, Hoffmann P, Arnesen H, Ilebekk A (2011)
    Circulating CD34⁺ progenitor cells and growth factors in patients treated with PCI for acute myocardial infarction or stable angina pectoris
    Scand J Clin Lab Invest, 71 (4), 322-9
    DOI 10.3109/00365513.2011.565367, PubMed 21463159
  8. Hopp E, Lunde K, Solheim S, Aakhus S, Arnesen H, Forfang K, Edvardsen T, Smith HJ (2011)
    Regional myocardial function after intracoronary bone marrow cell injection in reperfused anterior wall infarction - a cardiovascular magnetic resonance tagging study
    J Cardiovasc Magn Reson, 13, 22
    DOI 10.1186/1532-429X-13-22, PubMed 21414223
  9. Karlsen A, Svendsen M, Seljeflot I, Sommernes MA, Sexton J, Brevik A, Erlund I, Serafini M, Bastani N, Remberg SF, Borge GI, Carlsen MH, Bøhn SK, Myhrstad MC, Dragsted LO, Duttaroy AK, Haffner K, Laake P, Drevon CA, Arnesen H, Collins A, Tonstad S, Blomhoff R (2011)
    Compliance, tolerability and safety of two antioxidant-rich diets: a randomised controlled trial in male smokers
    Br J Nutr, 106 (4), 557-71
    DOI 10.1017/S0007114511000353, PubMed 21806852
  10. Kirkhus B, Lamglait A, Eilertsen KE, Falch E, Haider T, Vik H, Hoem N, Hagve TA, Basu S, Olsen E, Seljeflot I, Nyberg L, Elind E, Ulven SM (2011)
    Effects of similar intakes of marine n-3 fatty acids from enriched food products and fish oil on cardiovascular risk markers in healthy human subjects
    Br J Nutr, 107 (9), 1339-49
    DOI 10.1017/S0007114511004508, PubMed 21917191
  11. Knudsen EC, Seljeflot I, Abdelnoor M, Eritsland J, Mangschau A, Müller C, Arnesen H, Andersen GO (2011)
    Impact of newly diagnosed abnormal glucose regulation on long-term prognosis in low risk patients with ST-elevation myocardial infarction: A follow-up study
    BMC Endocr Disord, 11, 14
    DOI 10.1186/1472-6823-11-14, PubMed 21801387
  12. Knudsen EC, Seljeflot I, Abdelnoor M, Eritsland J, Mangschau A, Müller C, Arnesen H, Andersen GØ (2011)
    Elevated levels of PAI-1 activity and t-PA antigen are associated with newly diagnosed abnormal glucose regulation in patients with ST-elevation myocardial infarction
    J Thromb Haemost, 9 (8), 1468-74
    DOI 10.1111/j.1538-7836.2011.04377.x, PubMed 21624046
  13. Kubon C, Mistry NB, Grundvold I, Halvorsen S, Kjeldsen SE, Westheim AS (2011)
    The role of beta-blockers in the treatment of chronic heart failure
    Trends Pharmacol Sci, 32 (4), 206-12
    DOI 10.1016/j.tips.2011.01.006, PubMed 21376403
  14. Mistry N, Abdelnoor M, Seljeflot I, Hoffmann P, Bøhmer E, Bjørnerheim R, Kjeldsen SE, Halvorsen S (2011)
    Amino-terminal pro-B-type natriuretic peptide (NT-proBNP) levels 3 months after myocardial infarction are more strongly associated with magnetic resonance-determined ejection fraction than NTproBNP levels in the acute phase
    J Card Fail, 17 (6), 479-86
    DOI 10.1016/j.cardfail.2011.02.006, PubMed 21624736
  15. Mistry N, Beitnes JO, Halvorsen S, Abdelnoor M, Hoffmann P, Kjeldsen SE, Smith G, Aakhus S, Bjørnerheim R (2011)
    Assessment of left ventricular function in ST-elevation myocardial infarction by global longitudinal strain: a comparison with ejection fraction, infarct size, and wall motion score index measured by non-invasive imaging modalities
    Eur J Echocardiogr, 12 (9), 678-83
    DOI 10.1093/ejechocard/jer113, PubMed 21810829
  16. Opstad TB, Pettersen AÅ, Arnesen H, Seljeflot I (2011)
    Circulating levels of IL-18 are significantly influenced by the IL-18 +183 A/G polymorphism in coronary artery disease patients with diabetes type 2 and the metabolic syndrome: an observational study
    Cardiovasc Diabetol, 10, 110
    DOI 10.1186/1475-2840-10-110, PubMed 22141572
  17. Opstad TB, Pettersen AA, Weiss TW, Akra S, Øvstebø R, Arnesen H, Seljeflot I (2011)
    Genetic variation, gene-expression and circulating levels of matrix metalloproteinase-9 in patients with stable coronary artery disease
    Clin Chim Acta, 413 (1-2), 113-20
    DOI 10.1016/j.cca.2011.09.004, PubMed 21963461
  18. Patrono C, Andreotti F, Arnesen H, Badimon L, Baigent C, Collet JP, De Caterina R, Gulba D, Huber K, Husted S, Kristensen SD, Morais J, Neumann FJ, Rasmussen LH, Siegbahn A, Steg PG, Storey RF, Van de Werf F, Verheugt F (2011)
    Antiplatelet agents for the treatment and prevention of atherothrombosis
    Eur Heart J, 32 (23), 2922-32
    DOI 10.1093/eurheartj/ehr373, PubMed 22019823
  19. Pettersen AA, Arnesen H, Opstad TB, Seljeflot I (2011)
    The influence of CYP 2C19*2 polymorphism on platelet function testing during single antiplatelet treatment with clopidogrel
    Thromb J, 9, 4
    DOI 10.1186/1477-9560-9-4, PubMed 21426546
  20. Skretteberg PT, Grundvold I, Kjeldsen SE, Erikssen JE, Sandvik L, Liestøl K, Erikssen G, Pedersen TR, Bodegard J (2011)
    HDL-cholesterol and prediction of coronary heart disease: modified by physical fitness? A 28-year follow-up of apparently healthy men
    Atherosclerosis, 220 (1), 250-6
    DOI 10.1016/j.atherosclerosis.2011.10.009, PubMed 22062589
  21. Solheim S, Seljeflot I, Lunde K, Bratseth V, Aakhus S, Forfang K, Arnesen H (2011)
    The influence of intracoronary injection of bone marrow cells on prothrombotic markers in patients with acute myocardial infarction
    Thromb Res, 130 (5), 765-8
    DOI 10.1016/j.thromres.2011.11.045, PubMed 22192151
  22. Steg PG, Huber K, Andreotti F, Arnesen H, Atar D, Badimon L, Bassand JP, De Caterina R, Eikelboom JA, Gulba D, Hamon M, Helft G, Fox KA, Kristensen SD, Rao SV, Verheugt FW, Widimsky P, Zeymer U, Collet JP (2011)
    Bleeding in acute coronary syndromes and percutaneous coronary interventions: position paper by the Working Group on Thrombosis of the European Society of Cardiology
    Eur Heart J, 32 (15), 1854-64
    DOI 10.1093/eurheartj/ehr204, PubMed 21715717
  23. Tømte O, Andersen GØ, Jacobsen D, Drægni T, Auestad B, Sunde K (2011)
    Strong and weak aspects of an established post-resuscitation treatment protocol-A five-year observational study
    Resuscitation, 82 (9), 1186-93
    DOI 10.1016/j.resuscitation.2011.05.003, PubMed 21636202
  24. Weiss TW, Arnesen H, Trøseid M, Kaun C, Hjerkinn EM, Huber K, Wojta J, Seljeflot I (2011)
    Adipose tissue expression of interleukin-18 mRNA is elevated in subjects with metabolic syndrome and independently associated with fasting glucose
    Wien Klin Wochenschr, 123 (21-22), 650-4
    DOI 10.1007/s00508-011-0028-6, PubMed 21842238
  25. Weiss TW, Eritsland J (2011)
    ECG in acute myocardial infarction - inferior not anterior but left and right Reply
    Wien. Klin. Wochen., 123 (15-16), 520
  26. Weiss TW, Eritsland J (2011)
    Anterior or inferior?
    Wien Klin Wochenschr, 123 (9-10), 268
    DOI 10.1007/s00508-010-1521-z, PubMed 21253773
  27. Weiss TW, Seljeflot I, Hjerkinn EM, Arnesen H (2011)
    Adipose tissue pro-inflammatory gene expression is associated with cardiovascular disease
    Int J Clin Pract, 65 (9), 939-44
    DOI 10.1111/j.1742-1241.2011.02717.x, PubMed 21849008

Publications 2010

  1. Arnesen H (2010)
    Thrombocardiology: an update
    Expert Rev Cardiovasc Ther, 8 (3), 331-3
    DOI 10.1586/erc.10.9, PubMed 20222811
  2. Arnesen H, Seljeflot I (2010)
    Studies on very long chain marine n-3 fatty acids in patients with atherosclerotic heart disease with special focus on mechanisms, dosage and formulas of supplementation
    Cell Mol Biol (Noisy-le-grand), 56 (1), 18-27
    DOI 10.1170/T875, PubMed 20196966
  3. Beitnes JO, Gjesdal O, Lunde K, Solheim S, Edvardsen T, Arnesen H, Forfang K, Aakhus S (2010)
    Left ventricular systolic and diastolic function improve after acute myocardial infarction treated with acute percutaneous coronary intervention, but are not influenced by intracoronary injection of autologous mononuclear bone marrow cells: a 3 year serial echocardiographic sub-study of the randomized-controlled ASTAMI study
    Eur J Echocardiogr, 12 (2), 98-106
    DOI 10.1093/ejechocard/jeq116, PubMed 20851818
  4. Borgia F, Goodman SG, Halvorsen S, Cantor WJ, Piscione F, Le May MR, Fernández-Avilés F, Sánchez PL, Dimopoulos K, Scheller B, Armstrong PW, Di Mario C (2010)
    Early routine percutaneous coronary intervention after fibrinolysis vs. standard therapy in ST-segment elevation myocardial infarction: a meta-analysis
    Eur Heart J, 31 (17), 2156-69
    DOI 10.1093/eurheartj/ehq204, PubMed 20601393
  5. Bøhmer E, Seljeflot I, Arnesen H, Hoffmann P, Abdelnoor M, Halvorsen S (2010)
    The association between metabolic syndrome and infarct size in patients with acute myocardial infarction
    Scand J Clin Lab Invest, 70 (4), 287-93
    DOI 10.3109/00365513.2010.481819, PubMed 20429699
  6. Bøhn SK, Myhrstad MC, Thoresen M, Holden M, Karlsen A, Tunheim SH, Erlund I, Svendsen M, Seljeflot I, Moskaug JO, Duttaroy AK, Laake P, Arnesen H, Tonstad S, Collins A, Drevon CA, Blomhoff R (2010)
    Blood cell gene expression associated with cellular stress defense is modulated by antioxidant-rich food in a randomised controlled clinical trial of male smokers
    BMC Med, 8, 54
    DOI 10.1186/1741-7015-8-54, PubMed 20846424
  7. Grimsmo J, Arnesen H (2010)
    The relationship between exercise and the healthy heart: trouble in paradise?
    Expert Rev Cardiovasc Ther, 8 (8), 1047-8
    DOI 10.1586/erc.10.69, PubMed 20670180
  8. Grimsmo J, Grundvold I, Maehlum S, Arnesen H (2010)
    High prevalence of atrial fibrillation in long-term endurance cross-country skiers: echocardiographic findings and possible predictors--a 28-30 years follow-up study
    Eur J Cardiovasc Prev Rehabil, 17 (1), 100-5
    DOI 10.1097/HJR.0b013e32833226be, PubMed 20065854
  9. Grimsmo J, Grundvold I, Maehlum S, Arnesen H (2010)
    Echocardiographic evaluation of aged male cross country skiers
    Scand J Med Sci Sports, 21 (3), 412-9
    DOI 10.1111/j.1600-0838.2009.01054.x, PubMed 20136762
  10. Grøgaard HK, Seljeflot I, Lunde K, Solheim S, Aakhus S, Forfang K, Arnesen H, Ilebekk A (2010)
    Cell treatment after acute myocardial infarction prevents early decline in circulating IGF-1
    Scand Cardiovasc J, 44 (5), 267-72
    DOI 10.3109/14017431.2010.490949, PubMed 21080844
  11. Halvorsen S, Huber K (2010)
    The role of fibrinolysis in the era of primary percutaneous coronary intervention
    Thromb Haemost, 105 (3), 390-5
    DOI 10.1160/TH10-08-0513, PubMed 21136014
  12. Knudsen EC, Seljeflot I, Michael A, Eritsland J, Mangschau A, Müller C, Arnesen H, Andersen GØ (2010)
    Increased levels of CRP and MCP-1 are associated with previously unknown abnormal glucose regulation in patients with acute STEMI: a cohort study
    Cardiovasc Diabetol, 9, 47
    DOI 10.1186/1475-2840-9-47, PubMed 20809989
  13. Kringen MK, Haug KB, Grimholt RM, Stormo C, Narum S, Opdal MS, Fosen JT, Piehler AP, Johansen PW, Seljeflot I, Berg JP, Brørs O (2010)
    Genetic variation of VKORC1 and CYP4F2 genes related to warfarin maintenance dose in patients with myocardial infarction
    J Biomed Biotechnol, 2011, 739751
    DOI 10.1155/2011/739751, PubMed 21127708
  14. Kringen MK, Narum S, Lygren I, Seljeflot I, Sandset PM, Trøseid AM, Johansen PW, Brørs O, Holthe MR (2010)
    Reduced platelet function and role of drugs in acute gastrointestinal bleeding
    Basic Clin Pharmacol Toxicol, 108 (3), 194-201
    DOI 10.1111/j.1742-7843.2010.00643.x, PubMed 21118353
  15. Lie I, Arnesen H, Sandvik L, Hamilton G, Bunch EH (2010)
    Predictors for physical and mental health 6 months after coronary artery bypass grafting: a cohort study
    Eur J Cardiovasc Nurs, 9 (4), 238-43
    DOI 10.1016/j.ejcnurse.2010.02.001, PubMed 20219433
  16. Limalanathan S, Andersen GØ, Hoffmann P, Kløw NE, Abdelnoor M, Eritsland J (2010)
    Rationale and design of the POSTEMI (postconditioning in ST-elevation myocardial infarction) study
    Cardiology, 116 (2), 103-9
    DOI 10.1159/000316965, PubMed 20588018
  17. Lip GY, Huber K, Andreotti F, Arnesen H, Airaksinen JK, Cuisset T, Kirchhof P, Marín F, Consensus Document of European Society of Cardiology Working Group on Thrombosis (2010)
    Antithrombotic management of atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing coronary stenting: executive summary--a Consensus Document of the European Society of Cardiology Working Group on Thrombosis, endorsed by the European Heart Rhythm Association (EHRA) and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)
    Eur Heart J, 31 (11), 1311-8
    DOI 10.1093/eurheartj/ehq117, PubMed 20447945
  18. Mistry N, Bøhmer E, Hoffmann P, Müller C, Bjørnerheim R, Kjeldsen SE, Halvorsen S (2010)
    Left ventricular function in acute myocardial infarction treated with thrombolysis followed by early versus late invasive strategy
    Am Heart J, 160 (1), 73-9
    DOI 10.1016/j.ahj.2010.04.011, PubMed 20598975
  19. Mistry N, Halvorsen S, Hoffmann P, Müller C, Bøhmer E, Kjeldsen SE, Bjørnerheim R (2010)
    Assessment of left ventricular function with magnetic resonance imaging vs. echocardiography, contrast echocardiography, and single-photon emission computed tomography in patients with recent ST-elevation myocardial infarction
    Eur J Echocardiogr, 11 (9), 793-800
    DOI 10.1093/ejechocard/jeq069, PubMed 20525984
  20. Nicholls M, Halvorsen S (2010)
    Spotlight: Sigrun Halvorsen, MD, PhD, FESC
    Circulation, 121 (2), F10-F11
  21. Nilsson BB, Westheim A, Risberg MA, Arnesen H, Seljeflot I (2010)
    No effect of group-based aerobic interval training on N-terminal pro- B-type natriuretic peptide levels in patients with chronic heart failure
    Scand Cardiovasc J, 44 (4), 223-9
    DOI 10.3109/14017431.2010.496869, PubMed 20636229
  22. Opstad TB, Pettersen AA, Bratseth V, Arnesen H, Seljeflot I (2010)
    The influence of tissue factor and tissue factor pathway inhibitor polymorphisms on thrombin generation in stable coronary artery disease
    Pathophysiol Haemost Thromb, 37 (2-4), 98-103
    DOI 10.1159/000327491, PubMed 21555871
  23. Opstad TB, Pettersen AA, Weiss T, Arnesen H, Seljeflot I (2010)
    Gender differences of polymorphisms in the TF and TFPI genes, as related to phenotypes in patients with coronary heart disease and type-2 diabetes
    Thromb J, 8, 7
    DOI 10.1186/1477-9560-8-7, PubMed 20444258
  24. Sandset PM, Arnesen H, Jacobsen AF, Wergeland H (2010)
    Prophylaxis against prosthetic mitral valve thrombosis with unfractionated heparin administered by an elastometric infusion pump
    Thromb Res, 126 (3), e232-4
    DOI 10.1016/j.thromres.2010.05.005, PubMed 20553950
  25. Seljeflot I, Nilsson BB, Westheim AS, Bratseth V, Arnesen H (2010)
    The L-arginine-asymmetric dimethylarginine ratio is strongly related to the severity of chronic heart failure. No effects of exercise training
    J Card Fail, 17 (2), 135-42
    DOI 10.1016/j.cardfail.2010.09.003, PubMed 21300303
  26. Solheim S, Seljeflot I, Lunde K, Bjørnerheim R, Aakhus S, Forfang K, Arnesen H (2010)
    Frequency of left ventricular thrombus in patients with anterior wall acute myocardial infarction treated with percutaneous coronary intervention and dual antiplatelet therapy
    Am J Cardiol, 106 (9), 1197-200
    DOI 10.1016/j.amjcard.2010.06.043, PubMed 21029812
  27. Sverdrup Ø, Jensen T, Solheim S, Gjesdal K (2010)
    Training auscultatory skills: computer simulated heart sounds or additional bedside training? A randomized trial on third-year medical students
    BMC Med Educ, 10, 3
    DOI 10.1186/1472-6920-10-3, PubMed 20082701
  28. Trøseid M, Seljeflot I, Arnesen H (2010)
    The role of interleukin-18 in the metabolic syndrome
    Cardiovasc Diabetol, 9, 11
    DOI 10.1186/1475-2840-9-11, PubMed 20331890
  29. Tveit A, Arnesen H, Smith P, Bratseth V, Seljeflot I (2010)
    L-arginine, asymmetric dimethylarginine and rhythm outcome after electrical cardioversion for atrial fibrillation
    Cardiology, 117 (3), 176-80
    DOI 10.1159/000321402, PubMed 21063118
  30. Weiss TW, Furenes EB, Trøseid M, Solheim S, Hjerkinn EM, Seljeflot I, Arnesen H (2010)
    Prediction of cardiovascular events by matrix metalloproteinase (MMP)-9 in elderly men
    Thromb Haemost, 103 (3), 679-81
    DOI 10.1160/TH09-05-0317, PubMed 20076844
  31. Weiss TW, Schumacher S, Kaun C, Katsaros KM, Trøseid M, Huber K, Maurer G, Wojta J (2010)
    Association between smoking and presence of mycoplasma pneumoniae in circulating leukocytes
    Swiss Med Wkly, 140, w13105
    DOI 10.4414/smw.2010.13105, PubMed 20927683

Publications 2009

  1. Beitnes JO, Hopp E, Lunde K, Solheim S, Arnesen H, Brinchmann JE, Forfang K, Aakhus S (2009)
    Long-term results after intracoronary injection of autologous mononuclear bone marrow cells in acute myocardial infarction: the ASTAMI randomised, controlled study
    Heart, 95 (24), 1983-9
    DOI 10.1136/hrt.2009.178913, PubMed 19833610
  2. Bøhmer E, Hoffmann P, Abdelnoor M, Arnesen H, Halvorsen S (2009)
    Efficacy and safety of immediate angioplasty versus ischemia-guided management after thrombolysis in acute myocardial infarction in areas with very long transfer distances results of the NORDISTEMI (NORwegian study on DIstrict treatment of ST-elevation myocardial infarction)
    J Am Coll Cardiol, 55 (2), 102-10
    DOI 10.1016/j.jacc.2009.08.007, PubMed 19747792
  3. Bøhmer E, Hoffmann P, Abdelnoor M, Seljeflot I, Halvorsen S (2009)
    Troponin T concentration 3 days after acute ST-elevation myocardial infarction predicts infarct size and cardiac function at 3 months
    Cardiology, 113 (3), 207-12
    DOI 10.1159/000201991, PubMed 19218804
  4. Diette GB, Sajjan SG, Skinner EA, Weiss TW, Wu AW, Markson LE (2009)
    Using the pediatric asthma therapy assessment questionnaire to measure asthma control and healthcare utilization in children
    Patient, 2 (4), 233-41
    DOI 10.2165/11313820-000000000-00000, PubMed 22273244
  5. Furenes EB, Arnesen H, Solheim S, Grøgaard HK, Hoffmann P, Seljeflot I (2009)
    The profile of circulating metalloproteinases after PCI in patients with acute myocardial infarction or stable angina
    Thromb Res, 124 (5), 560-4
    DOI 10.1016/j.thromres.2009.04.001, PubMed 19410278
  6. Grimsmo J, Arnesen H, Maehlum S (2009)
    Changes in cardiorespiratory function in different groups of former and still active male cross-country skiers: a 28-30-year follow-up study
    Scand J Med Sci Sports, 20 (1), e151-61
    DOI 10.1111/j.1600-0838.2009.00931.x, PubMed 19422661
  7. Halvorsen S, Risøe C (2009)
    [Symptoms and diagnosis of coronary heart disease in women]
    Tidsskr Nor Laegeforen, 129 (18), 1853-7
    DOI 10.4045/tidsskr.09.0115, PubMed 19844276
  8. Hegbom F, Tveit A, Grundvold I, Arnesen H, Smith P (2009)
    Effects of angiotensin receptor blockade on serial P-wave signal-averaged electrocardiograms after electrical cardioversion of persistent atrial fibrillation
    Europace, 11 (10), 1301-7
    DOI 10.1093/europace/eup220, PubMed 19666643
  9. Jarai R, Kaun C, Weiss TW, Speidl WS, Rychli K, Maurer G, Huber K, Wojta J (2009)
    Human cardiac fibroblasts express B-type natriuretic peptide: fluvastatin ameliorates its up-regulation by interleukin-1alpha, tumour necrosis factor-alpha and transforming growth factor-beta
    J Cell Mol Med, 13 (11-12), 4415-21
    DOI 10.1111/j.1582-4934.2009.00704.x, PubMed 19228263
  10. Knudsen EC, Seljeflot I, Abdelnoor M, Eritsland J, Mangschau A, Arnesen H, Andersen GO (2009)
    Abnormal glucose regulation in patients with acute ST- elevation myocardial infarction-a cohort study on 224 patients
    Cardiovasc Diabetol, 8, 6
    DOI 10.1186/1475-2840-8-6, PubMed 19183453
  11. Kuliczkowski W, Witkowski A, Polonski L, Watala C, Filipiak K, Budaj A, Golanski J, Sitkiewicz D, Pregowski J, Gorski J, Zembala M, Opolski G, Huber K, Arnesen H, Kristensen SD, De Caterina R (2009)
    Interindividual variability in the response to oral antiplatelet drugs: a position paper of the Working Group on antiplatelet drugs resistance appointed by the Section of Cardiovascular Interventions of the Polish Cardiac Society, endorsed by the Working Group on Thrombosis of the European Society of Cardiology
    Eur Heart J, 30 (4), 426-35
    DOI 10.1093/eurheartj/ehn562, PubMed 19174428
  12. Lie I, Arnesen H, Sandvik L, Hamilton G, Bunch EH (2009)
    Health-related quality of life after coronary artery bypass grafting. The impact of a randomised controlled home-based intervention program
    Qual Life Res, 18 (2), 201-7
    DOI 10.1007/s11136-008-9438-y, PubMed 19169899
  13. Lip GY, Huber K, Andreotti F, Arnesen H, Airaksinen KJ, Cuisset T, Kirchhof P, Marín F, European Society of Cardiology Working Group on Thrombosis (2009)
    Management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous coronary intervention/ stenting
    Thromb Haemost, 103 (1), 13-28
    DOI 10.1160/TH09-08-0580, PubMed 20062939
  14. Taraldsrud E, Grøgaard HK, Solheim S, Lunde K, Fløisand Y, Arnesen H, Seljeflot I, Egeland T (2009)
    Age and stress related phenotypical changes in bone marrow CD34+ cells
    Scand J Clin Lab Invest, 69 (1), 79-84
    DOI 10.1080/00365510802419447, PubMed 18836945
  15. Trøseid M, Arnesen H, Hjerkinn EM, Seljeflot I (2009)
    Serum levels of interleukin-18 are reduced by diet and n-3 fatty acid intervention in elderly high-risk men
    Metabolism, 58 (11), 1543-9
    DOI 10.1016/j.metabol.2009.04.031, PubMed 19595382
  16. Trøseid M, Lappegård KT, Mollnes TE, Arnesen H, Seljeflot I (2009)
    The effect of exercise on serum levels of interleukin-18 and components of the metabolic syndrome
    Metab Syndr Relat Disord, 7 (6), 579-84
    DOI 10.1089/met.2009.0003, PubMed 19900154
  17. Tveit A, Bollmann A, Seljeflot I, Husser D, Stridh M, Sörnmo L, Arnesen H, Olsson SB, Smith P (2009)
    Relation between atrial fibrillatory rate and markers of inflammation and haemostasis in persistent human atrial fibrillation
    Thromb Haemost, 101 (3), 601-3
    DOI 10.1160/TH08-07-0482, PubMed 19277431
  18. Van de Werf F, Bax J, Betriu A, Blomstrom-Lundqvist C, Crea F, Falk V, Filippatos G, Fox K, Huber K, Kastrati A, Rosengren A, Steg PG, Tubaro M, Verheugt F, Weidinger F, Weis M, Task Force per il Trattamento dell'Infarto Miocardico Acuto con, Sopraslivellamento del Tratto ST della Società Europea di Cardiologia, Vahanian A, Camm J, De Caterina R, Dean V, Dickstein K, Filippatos G, Funck-Brentano C et al. (2009)
    [Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation]
    G Ital Cardiol (Rome), 10 (7), 450-89
    PubMed 19761103
  19. Weiss TW, Stensaeth KH, Eritsland J (2009)
    Myocarditis in a juvenile patient with influenza A virus infection
    Eur Heart J, 31 (3), 277
    DOI 10.1093/eurheartj/ehp566, PubMed 20007610
  20. Wennersberg MH, Smedman A, Turpeinen AM, Retterstøl K, Tengblad S, Lipre E, Aro A, Mutanen P, Seljeflot I, Basu S, Pedersen JI, Mutanen M, Vessby B (2009)
    Dairy products and metabolic effects in overweight men and women: results from a 6-mo intervention study
    Am J Clin Nutr, 90 (4), 960-8
    DOI 10.3945/ajcn.2009.27664, PubMed 19710195

Publications 2008

  1. Andersen GØ (2008)
    Treatment of acute decompensated heart failure: harmful effects of high doses of loop diuretics?
    Cardiology, 113 (1), 9-11
    DOI 10.1159/000164148, PubMed 18931491
  2. Bringager CB, Friis S, Arnesen H, Dammen T (2008)
    Nine-year follow-up of panic disorder in chest pain patients: clinical course and predictors of outcome
    Gen Hosp Psychiatry, 30 (2), 138-46
    DOI 10.1016/j.genhosppsych.2007.12.009, PubMed 18291295
  3. Bringager CB, Gauer K, Arnesen H, Friis S, Dammen T (2008)
    Nonfearful panic disorder in chest-pain patients: status after nine-year follow-up
    Psychosomatics, 49 (5), 426-37
    DOI 10.1176/appi.psy.49.5.426, PubMed 18794512
  4. Brodin E, Seljeflot I, Arnesen H, Hurlen M, Appelbom H, Hansen JB (2008)
    Endogenous thrombin potential (ETP) in plasma from patients with AMI during antithrombotic treatment
    Thromb Res, 123 (4), 573-9
    DOI 10.1016/j.thromres.2008.03.018, PubMed 18474393
  5. Christensen AH, Ribic D, Solheim S, Gjesdal K (2008)
    [Occurrence of arrhythmias related to treatment of myocardial infarction]
    Tidsskr Nor Laegeforen, 128 (19), 2163-6
    PubMed 18846137
  6. Dammen T, Ekeberg Ø, Arnesen H, Friis S (2008)
    Health-related quality of life in non-cardiac chest pain patients with and without panic disorder
    Int J Psychiatry Med, 38 (3), 271-86
    DOI 10.2190/PM.38.3.d, PubMed 19069572
  7. Ellingsen I, Seljeflot I, Arnesen H, Tonstad S (2008)
    Vitamin C consumption is associated with less progression in carotid intima media thickness in elderly men: A 3-year intervention study
    Nutr Metab Cardiovasc Dis, 19 (1), 8-14
    DOI 10.1016/j.numecd.2008.01.006, PubMed 18472409
  8. Grundvold I, Tveit A, Smith P, Seljeflot I, Abdelnoor M, Arnesen H (2008)
    The predictive value of transthoracic echocardiographic variables for sinus rhythm maintenance after electrical cardioversion of atrial fibrillation. Results from the CAPRAF study, a prospective, randomized, placebo-controlled study
    Cardiology, 111 (1), 30-5
    DOI 10.1159/000113424, PubMed 18239389
  9. Haug KBF, Sharikabad MN, Kringen MK, Narum S, Sjaatil ST, Johansen PW, Kierulf P, Seljeflot I, Arnesen H, Brørs O (2008)
    Warfarin dose and INR related to genotypes of CYP2C9 and VKORC1 in patients with myocardial infarction
    Thromb J, 6, 7
    DOI 10.1186/1477-9560-6-7, PubMed 18559094
  10. Hurlen M, Arnesen H (2008)
    Oral anticoagulation after myocardial infarction
    Herz, 33 (1), 38-43
    DOI 10.1007/s00059-008-3074-8, PubMed 18273576
  11. Lunde K, Solheim S, Forfang K, Arnesen H, Brinch L, Bjørnerheim R, Ragnarsson A, Egeland T, Endresen K, Ilebekk A, Mangschau A, Aakhus S (2008)
    Anterior myocardial infarction with acute percutaneous coronary intervention and intracoronary injection of autologous mononuclear bone marrow cells: safety, clinical outcome, and serial changes in left ventricular function during 12-months' follow-up
    J Am Coll Cardiol, 51 (6), 674-6
    DOI 10.1016/j.jacc.2007.10.032, PubMed 18261689
  12. Smith PJ, Hurlen M, Abdelnoor M, Arnesen H (2008)
    Less benefit from warfarin in diabetics after myocardial infarction?
    Cardiology, 111 (3), 161-6
    DOI 10.1159/000121598, PubMed 18434719
  13. Solheim S, Grøgaard HK, Hoffmann P, Arnesen H, Seljeflot I (2008)
    Inflammatory responses after percutaneous coronary intervention in patients with acute myocardial infarction or stable angina pectoris
    Scand J Clin Lab Invest, 68 (7), 555-62
    DOI 10.1080/00365510701884584, PubMed 19378426
  14. Solheim S, Seljeflot I, Lunde K, Aukrust P, Yndestad A, Grøgaard HK, Aakhus S, Forfang K, Arnesen H (2008)
    Inflammatory responses after intracoronary injection of autologous mononuclear bone marrow cells in patients with acute myocardial infarction
    Am Heart J, 155 (1), 55.e1-9
    DOI 10.1016/j.ahj.2007.10.005, PubMed 18082489
  15. Tveit A, Grundvold I, Olufsen M, Seljeflot I, Abdelnoor M, Arnesen H, Smith P (2008)
    Angiotensin receptor blockers in the prevention of atrial fibrillation recurrence: Need for a definitive trial
    Int. J. Cardiol., 127 (2), 278-279
  16. Tveit A, Seljeflot I, Grundvold I, Abdelnoor M, Arnesen H, Smith P (2008)
    Candesartan, NT-proBNP and recurrence of atrial fibrillation after electrical cardioversion
    Int J Cardiol, 131 (2), 234-9
    DOI 10.1016/j.ijcard.2007.10.028, PubMed 18201783
 
Page visits: 5114